HRP20211678T1 - N-supstituirani derivati indola kao modulatori receptora pge2 - Google Patents
N-supstituirani derivati indola kao modulatori receptora pge2 Download PDFInfo
- Publication number
- HRP20211678T1 HRP20211678T1 HRP20211678TT HRP20211678T HRP20211678T1 HR P20211678 T1 HRP20211678 T1 HR P20211678T1 HR P20211678T T HRP20211678T T HR P20211678TT HR P20211678 T HRP20211678 T HR P20211678T HR P20211678 T1 HRP20211678 T1 HR P20211678T1
- Authority
- HR
- Croatia
- Prior art keywords
- pyrimidin
- indol
- fluoro
- methoxy
- ethylamino
- Prior art date
Links
- -1 N-substituted indole Chemical class 0.000 title claims 55
- 102000008866 Prostaglandin E receptors Human genes 0.000 title 1
- 108010088540 Prostaglandin E receptors Proteins 0.000 title 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 70
- 239000001257 hydrogen Substances 0.000 claims 70
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 60
- 125000000217 alkyl group Chemical group 0.000 claims 53
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 48
- 125000000753 cycloalkyl group Chemical group 0.000 claims 42
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 30
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 28
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 24
- 150000001875 compounds Chemical class 0.000 claims 22
- 125000001424 substituent group Chemical group 0.000 claims 21
- 150000003839 salts Chemical class 0.000 claims 20
- 229910052736 halogen Inorganic materials 0.000 claims 19
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 19
- 150000002367 halogens Chemical class 0.000 claims 17
- 125000004093 cyano group Chemical group *C#N 0.000 claims 16
- 125000001153 fluoro group Chemical group F* 0.000 claims 16
- 150000002431 hydrogen Chemical class 0.000 claims 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 15
- 125000004430 oxygen atom Chemical group O* 0.000 claims 15
- 125000001072 heteroaryl group Chemical group 0.000 claims 14
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 12
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 11
- 125000003545 alkoxy group Chemical group 0.000 claims 11
- 125000001309 chloro group Chemical group Cl* 0.000 claims 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 10
- 125000002947 alkylene group Chemical group 0.000 claims 9
- 229910052757 nitrogen Inorganic materials 0.000 claims 8
- 229910052717 sulfur Inorganic materials 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 7
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 7
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 7
- 229910052760 oxygen Inorganic materials 0.000 claims 7
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 6
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 claims 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 5
- 229910052799 carbon Inorganic materials 0.000 claims 5
- 125000004432 carbon atom Chemical group C* 0.000 claims 5
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- 239000001301 oxygen Substances 0.000 claims 5
- 125000000335 thiazolyl group Chemical group 0.000 claims 5
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 125000002993 cycloalkylene group Chemical group 0.000 claims 4
- 125000006413 ring segment Chemical group 0.000 claims 4
- 239000011593 sulfur Substances 0.000 claims 4
- 125000004434 sulfur atom Chemical group 0.000 claims 4
- 125000001544 thienyl group Chemical group 0.000 claims 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 3
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 125000000842 isoxazolyl group Chemical group 0.000 claims 3
- 125000002971 oxazolyl group Chemical group 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- WZANTBKSCXLPER-UHFFFAOYSA-N 4-[6-[2-(2-chloro-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzoic acid Chemical compound ClC=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC WZANTBKSCXLPER-UHFFFAOYSA-N 0.000 claims 2
- HMDSDLURRRRLGX-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC HMDSDLURRRRLGX-UHFFFAOYSA-N 0.000 claims 2
- FXQJUIQGXOEANG-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(2-oxo-1,3-dihydrobenzimidazol-5-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC2=C(NC(N2)=O)C=C1)C#N)OC FXQJUIQGXOEANG-UHFFFAOYSA-N 0.000 claims 2
- 208000010061 Autosomal Dominant Polycystic Kidney Diseases 0.000 claims 2
- 201000009273 Endometriosis Diseases 0.000 claims 2
- 206010035664 Pneumonia Diseases 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 230000003143 atherosclerotic effect Effects 0.000 claims 2
- 208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 230000035558 fertility Effects 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 125000001041 indolyl group Chemical group 0.000 claims 2
- 230000000302 ischemic effect Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 230000004770 neurodegeneration Effects 0.000 claims 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 125000003831 tetrazolyl group Chemical group 0.000 claims 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 2
- SZLRHYVHNFQNMF-UHFFFAOYSA-N (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylate Chemical compound CC1=C(OC(O1)=O)COC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N SZLRHYVHNFQNMF-UHFFFAOYSA-N 0.000 claims 1
- MHBANBFOAQZFHJ-BQYQJAHWSA-N (E)-3-[3-ethoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]prop-2-enoic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)/C=C/C(=O)O MHBANBFOAQZFHJ-BQYQJAHWSA-N 0.000 claims 1
- GWEYPKZLUHKSPZ-UHFFFAOYSA-N 1-[2-[[6-(2-cyclopropylpyridin-4-yl)pyrimidin-4-yl]amino]ethyl]-7-fluoro-4-methoxyindole-2-carbonitrile Chemical compound C1(CC1)C1=NC=CC(=C1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N GWEYPKZLUHKSPZ-UHFFFAOYSA-N 0.000 claims 1
- YWJZIFFJGSSQDG-UHFFFAOYSA-N 1-[2-[[6-(2H-benzotriazol-5-yl)pyrimidin-4-yl]amino]ethyl]-7-fluoro-4-methoxyindole-2-carbonitrile Chemical compound N1=NNC2=C1C=CC(=C2)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N YWJZIFFJGSSQDG-UHFFFAOYSA-N 0.000 claims 1
- SNOZJEFBWVZJIL-UHFFFAOYSA-N 1-[2-[[6-(3-ethoxy-4-hydroxyphenyl)pyrimidin-4-yl]amino]ethyl]-7-fluoro-4-methoxyindole-2-carbonitrile Chemical compound C(C)OC=1C=C(C=CC=1O)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N SNOZJEFBWVZJIL-UHFFFAOYSA-N 0.000 claims 1
- UOZDOTPEYLRMLX-UHFFFAOYSA-N 1-[2-[[6-(3H-benzimidazol-5-yl)pyrimidin-4-yl]amino]ethyl]-7-fluoro-4-methoxyindole-2-carbonitrile Chemical compound N1C=NC2=C1C=CC(=C2)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N UOZDOTPEYLRMLX-UHFFFAOYSA-N 0.000 claims 1
- OAROFKKXHCFVDX-UHFFFAOYSA-N 1-[2-[[6-[2-(azetidin-1-yl)pyridin-4-yl]pyrimidin-4-yl]amino]ethyl]-7-fluoro-4-methoxyindole-2-carbonitrile Chemical compound N1(CCC1)C1=NC=CC(=C1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N OAROFKKXHCFVDX-UHFFFAOYSA-N 0.000 claims 1
- ZCTGTSRJOSXUDL-UHFFFAOYSA-N 1-[2-[[6-[3-ethoxy-4-(2H-tetrazol-5-yl)phenyl]pyrimidin-4-yl]amino]ethyl]-7-fluoro-4-methoxyindole-2-carbonitrile Chemical compound C(C)OC=1C=C(C=CC=1C1=NN=NN1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N ZCTGTSRJOSXUDL-UHFFFAOYSA-N 0.000 claims 1
- WHZJEJUQSXFCDU-UHFFFAOYSA-N 1-[2-[[6-[3-ethoxy-4-(2H-triazol-4-yl)phenyl]pyrimidin-4-yl]amino]ethyl]-7-fluoro-4-methoxyindole-2-carbonitrile Chemical compound C(C)OC=1C=C(C=CC=1C=1NN=NC=1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N WHZJEJUQSXFCDU-UHFFFAOYSA-N 0.000 claims 1
- UZFHAWXZSWGSOU-UHFFFAOYSA-N 1-[2-[[6-[4-(1,2-dimethylimidazol-4-yl)phenyl]pyrimidin-4-yl]amino]ethyl]-7-fluoro-4-methoxyindole-2-carbonitrile Chemical compound CN1C(=NC(=C1)C1=CC=C(C=C1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N)C UZFHAWXZSWGSOU-UHFFFAOYSA-N 0.000 claims 1
- YKYHNQLCVJDXGG-UHFFFAOYSA-N 1-[2-[[6-[4-(2,5-dimethyl-1H-imidazol-4-yl)phenyl]pyrimidin-4-yl]amino]ethyl]-7-fluoro-4-methoxyindole-2-carbonitrile Chemical compound CC=1NC(=C(N=1)C1=CC=C(C=C1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N)C YKYHNQLCVJDXGG-UHFFFAOYSA-N 0.000 claims 1
- DBEXLCRZYVLXIQ-UHFFFAOYSA-N 1-[2-[[6-[4-(2-cyclopropyl-1-methylimidazol-4-yl)phenyl]pyrimidin-4-yl]amino]ethyl]-7-fluoro-4-methoxyindole-2-carbonitrile Chemical compound C1(CC1)C=1N(C=C(N=1)C1=CC=C(C=C1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N)C DBEXLCRZYVLXIQ-UHFFFAOYSA-N 0.000 claims 1
- ICVOGTLXRFNRCI-UHFFFAOYSA-N 1-[2-[[6-[4-(2-cyclopropyl-1H-imidazol-5-yl)phenyl]pyrimidin-4-yl]amino]ethyl]-7-fluoro-4-methoxyindole-2-carbonitrile Chemical compound COc1ccc(F)c2n(CCNc3cc(ncn3)-c3ccc(cc3)-c3cnc([nH]3)C3CC3)c(cc12)C#N ICVOGTLXRFNRCI-UHFFFAOYSA-N 0.000 claims 1
- UTBBRYWZBCVFOA-UHFFFAOYSA-N 1-[3-ethoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]ethanol Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)C(C)O UTBBRYWZBCVFOA-UHFFFAOYSA-N 0.000 claims 1
- HIHIYAHPPCCWQV-UHFFFAOYSA-N 1-[4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-methoxyphenyl]-3-ethylurea Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)NC(=O)NCC)OC HIHIYAHPPCCWQV-UHFFFAOYSA-N 0.000 claims 1
- OHZPFROBINOYRT-UHFFFAOYSA-N 1-ethyl-3-[2-methoxy-4-[6-[2-(4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]urea Chemical compound C(C)NC(=O)NC1=C(C=C(C=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC=C12)OC)C)OC OHZPFROBINOYRT-UHFFFAOYSA-N 0.000 claims 1
- MNFUKETUVVWJQQ-UHFFFAOYSA-N 1-ethyl-3-[4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-methoxyphenyl]urea Chemical compound C(C)NC(=O)NC1=C(C=C(C=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)OC MNFUKETUVVWJQQ-UHFFFAOYSA-N 0.000 claims 1
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 claims 1
- FQEFOSLMGSULTO-UHFFFAOYSA-N 2-(dimethylamino)ethyl 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylate Chemical compound CN(CCOC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N)C FQEFOSLMGSULTO-UHFFFAOYSA-N 0.000 claims 1
- AVNYRMJDLYCTGA-UHFFFAOYSA-N 2-(ethylamino)-4-[6-[2-(4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)NC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC=C12)OC)C AVNYRMJDLYCTGA-UHFFFAOYSA-N 0.000 claims 1
- MOMJSYQKXSMPEF-UHFFFAOYSA-N 2-(ethylamino)-4-[6-[2-(6-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)NC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)C)C MOMJSYQKXSMPEF-UHFFFAOYSA-N 0.000 claims 1
- JBTCPYYWIDGVRH-UHFFFAOYSA-N 2-(ethylamino)-4-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)NC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)C)C JBTCPYYWIDGVRH-UHFFFAOYSA-N 0.000 claims 1
- IPUVTHYKQMTNQK-UHFFFAOYSA-N 2-(ethylamino)-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)NC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C IPUVTHYKQMTNQK-UHFFFAOYSA-N 0.000 claims 1
- FBKPTLLSKZOTAK-UHFFFAOYSA-N 2-(ethylamino)-6-fluoro-4-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)NC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)C)C)F FBKPTLLSKZOTAK-UHFFFAOYSA-N 0.000 claims 1
- DMISQJXWQXSQQJ-UHFFFAOYSA-N 2-(ethylamino)-6-fluoro-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(C)NC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)F DMISQJXWQXSQQJ-UHFFFAOYSA-N 0.000 claims 1
- OEWMEHSUNKMHSM-UHFFFAOYSA-N 2-[2-chloro-4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound ClC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N OEWMEHSUNKMHSM-UHFFFAOYSA-N 0.000 claims 1
- QFZUUNHBQHGZGS-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]anilino]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)OC)C)NCC(=O)O QFZUUNHBQHGZGS-UHFFFAOYSA-N 0.000 claims 1
- MARYMFUPCQSHEU-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]anilino]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)C)C)NCC(=O)O MARYMFUPCQSHEU-UHFFFAOYSA-N 0.000 claims 1
- UFJLPGHTGJNULB-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]anilino]acetic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)NCC(=O)O UFJLPGHTGJNULB-UHFFFAOYSA-N 0.000 claims 1
- HDIZQAQMLAOQHL-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]anilino]propanoic acid Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)NC(C(=O)O)C HDIZQAQMLAOQHL-UHFFFAOYSA-N 0.000 claims 1
- TYGGMCSFGYLJQN-UHFFFAOYSA-N 2-[2-ethoxy-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenoxy]acetic acid Chemical compound C(C)OC1=C(OCC(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C TYGGMCSFGYLJQN-UHFFFAOYSA-N 0.000 claims 1
- BUYKSHPPRRBWCM-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyanilino]acetic acid Chemical compound C(#N)C=1N(C2=CC=CC(=C2C=1)OC)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)NCC(=O)O)OCC BUYKSHPPRRBWCM-UHFFFAOYSA-N 0.000 claims 1
- QXNJMKMOKDUBBA-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenoxy]acetic acid Chemical compound C(#N)C=1N(C2=CC=CC(=C2C=1)OC)CCNC1=CC(=NC=N1)C1=CC(=C(OCC(=O)O)C=C1)OCC QXNJMKMOKDUBBA-UHFFFAOYSA-N 0.000 claims 1
- CQTZGWDGQCBGNG-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-5,6-difluoro-4-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyanilino]acetic acid Chemical compound C(#N)C=1N(C2=CC(=C(C(=C2C=1)C)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)NCC(=O)O)OCC CQTZGWDGQCBGNG-UHFFFAOYSA-N 0.000 claims 1
- OZHIVSCFIWYOBD-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-6,7-difluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyanilino]acetic acid Chemical compound C(#N)C=1N(C2=C(C(=CC(=C2C=1)OC)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)NCC(=O)O)OCC OZHIVSCFIWYOBD-UHFFFAOYSA-N 0.000 claims 1
- DXSIUIIEYOECSW-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-6,7-difluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenoxy]acetic acid Chemical compound C(#N)C=1N(C2=C(C(=CC(=C2C=1)OC)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(OCC(=O)O)C=C1)OCC DXSIUIIEYOECSW-UHFFFAOYSA-N 0.000 claims 1
- KBJYGIHEDKGFNG-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(trifluoromethoxy)phenoxy]acetic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(OCC(=O)O)C=C1)OC(F)(F)F KBJYGIHEDKGFNG-UHFFFAOYSA-N 0.000 claims 1
- NHRVNUJMIDIISR-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyanilino]-2-oxoacetic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)NC(C(=O)O)=O)OCC NHRVNUJMIDIISR-UHFFFAOYSA-N 0.000 claims 1
- JNRLCJYCOVTIHP-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyanilino]acetic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)NCC(=O)O)OCC JNRLCJYCOVTIHP-UHFFFAOYSA-N 0.000 claims 1
- MZMWOGXUEISJFB-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenoxy]acetic acid Chemical compound CCOc1cc(ccc1OCC(O)=O)-c1cc(NCCn2c(cc3c(OC)ccc(F)c23)C#N)ncn1 MZMWOGXUEISJFB-UHFFFAOYSA-N 0.000 claims 1
- KQSOWEUFYOQOLK-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenyl]-2-oxoacetic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)C(C(=O)O)=O)OCC KQSOWEUFYOQOLK-UHFFFAOYSA-N 0.000 claims 1
- ZESVRMZQUPEDON-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethylphenoxy]acetic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(OCC(=O)O)C=C1)CC ZESVRMZQUPEDON-UHFFFAOYSA-N 0.000 claims 1
- ZPFGZZHSJBZPOJ-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-7-fluoro-4-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenoxy]acetic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)C)F)CCNC1=CC(=NC=N1)C1=CC(=C(OCC(=O)O)C=C1)OCC ZPFGZZHSJBZPOJ-UHFFFAOYSA-N 0.000 claims 1
- RCJBCDBLRXCISU-UHFFFAOYSA-N 2-[4-[6-[2-(2-cyano-7-fluoroindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyanilino]acetic acid Chemical compound C(#N)C=1N(C2=C(C=CC=C2C=1)F)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)NCC(=O)O)OCC RCJBCDBLRXCISU-UHFFFAOYSA-N 0.000 claims 1
- YOUASVYVEKPGBI-UHFFFAOYSA-N 2-[4-[6-[2-(4-chloro-2-cyano-6,7-difluoroindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyanilino]acetic acid Chemical compound ClC1=C2C=C(N(C2=C(C(=C1)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)NCC(=O)O)OCC)C#N YOUASVYVEKPGBI-UHFFFAOYSA-N 0.000 claims 1
- RAWQYQKBBPEPRH-UHFFFAOYSA-N 2-[4-[6-[2-(4-chloro-2-cyano-6,7-difluoroindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenoxy]acetic acid Chemical compound ClC1=C2C=C(N(C2=C(C(=C1)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(OCC(=O)O)C=C1)OCC)C#N RAWQYQKBBPEPRH-UHFFFAOYSA-N 0.000 claims 1
- NPAUGLQKPIPYEU-UHFFFAOYSA-N 2-[4-[6-[2-(4-chloro-2-cyanoindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyanilino]acetic acid Chemical compound ClC1=C2C=C(N(C2=CC=C1)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)NCC(=O)O)OCC)C#N NPAUGLQKPIPYEU-UHFFFAOYSA-N 0.000 claims 1
- DRWHAVKZSYDGNU-UHFFFAOYSA-N 2-[4-[6-[2-(4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-1,3-thiazole-4-carboxylic acid Chemical compound COC1=C2C=C(N(C2=CC=C1)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)C=1SC=C(N=1)C(=O)O)C DRWHAVKZSYDGNU-UHFFFAOYSA-N 0.000 claims 1
- GSRXSQZBKJFJCA-UHFFFAOYSA-N 2-[4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-1,3-thiazole-4-carboxylic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)C=1SC=C(N=1)C(=O)O)C)OC GSRXSQZBKJFJCA-UHFFFAOYSA-N 0.000 claims 1
- OCTWYMNLLAITSK-UHFFFAOYSA-N 2-[4-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-1,3-thiazole-4-carboxylic acid Chemical compound Cc1cc2c(C)ccc(F)c2n1CCNc1cc(ncn1)-c1ccc(cc1)-c1nc(cs1)C(O)=O OCTWYMNLLAITSK-UHFFFAOYSA-N 0.000 claims 1
- CJPAWAFQOQGVOU-UHFFFAOYSA-N 2-[4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-1,3-thiazole-4-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)C=1SC=C(N=1)C(=O)O)C)OC CJPAWAFQOQGVOU-UHFFFAOYSA-N 0.000 claims 1
- SXAFFEASTDVLDN-UHFFFAOYSA-N 2-[5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carbonyl]oxyacetic acid Chemical compound C(=O)(O)COC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N SXAFFEASTDVLDN-UHFFFAOYSA-N 0.000 claims 1
- LBFFMPHMZJOYAU-UHFFFAOYSA-N 2-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-1H-indole-5-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C=1NC2=CC=C(C=C2C=1)C(=O)O LBFFMPHMZJOYAU-UHFFFAOYSA-N 0.000 claims 1
- OPIJOIGTZRVUHM-UHFFFAOYSA-N 2-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-4-(2-methylpropyl)-1,3-thiazole-5-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C=1SC(=C(N=1)CC(C)C)C(=O)O)C)OC OPIJOIGTZRVUHM-UHFFFAOYSA-N 0.000 claims 1
- GERCSRMJXZZRDM-UHFFFAOYSA-N 2-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-4-methoxy-1,3-thiazole-5-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C=1SC(=C(N=1)OC)C(=O)O)C)OC GERCSRMJXZZRDM-UHFFFAOYSA-N 0.000 claims 1
- RUESVCKFJLIQRC-UHFFFAOYSA-N 2-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-4-propan-2-yloxy-1,3-thiazole-5-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C=1SC(=C(N=1)OC(C)C)C(=O)O)C)OC RUESVCKFJLIQRC-UHFFFAOYSA-N 0.000 claims 1
- DUDMWKCXNCNMIW-UHFFFAOYSA-N 2-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-4-propoxy-1,3-thiazole-5-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C=1SC(=C(N=1)OCCC)C(=O)O)C)OC DUDMWKCXNCNMIW-UHFFFAOYSA-N 0.000 claims 1
- SXXUHGWQTXFLIF-UHFFFAOYSA-N 2-butoxy-4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-6-fluorobenzoic acid Chemical compound C(CCC)OC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N)F SXXUHGWQTXFLIF-UHFFFAOYSA-N 0.000 claims 1
- JVHFJYPMXVYSFZ-UHFFFAOYSA-N 2-butoxy-4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(CCC)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N JVHFJYPMXVYSFZ-UHFFFAOYSA-N 0.000 claims 1
- CFSLHKZQVBWBLT-UHFFFAOYSA-N 2-butoxy-4-[6-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(CCC)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C(=C12)F)F)OC)C CFSLHKZQVBWBLT-UHFFFAOYSA-N 0.000 claims 1
- OIINOTYOFFQZBW-UHFFFAOYSA-N 2-butoxy-4-[6-[2-(6-chloro-7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(CCC)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C(=C12)F)Cl)OC)C OIINOTYOFFQZBW-UHFFFAOYSA-N 0.000 claims 1
- LSDHKKJFFFOXFD-UHFFFAOYSA-N 2-butoxy-4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(CCC)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)OC)C LSDHKKJFFFOXFD-UHFFFAOYSA-N 0.000 claims 1
- GZAVJEJRJBYYFI-UHFFFAOYSA-N 2-butoxy-4-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(CCC)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)C)C GZAVJEJRJBYYFI-UHFFFAOYSA-N 0.000 claims 1
- HZTYACCKCSVPQR-UHFFFAOYSA-N 2-butoxy-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(CCC)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C HZTYACCKCSVPQR-UHFFFAOYSA-N 0.000 claims 1
- PPSNTUJJALBYGP-UHFFFAOYSA-N 2-butoxy-6-chloro-4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(CCC)OC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N)Cl PPSNTUJJALBYGP-UHFFFAOYSA-N 0.000 claims 1
- ACMLGOZEKOERDS-LZMSFWOYSA-N 2-butoxy-6-chloro-4-[6-[[1,1,2,2-tetradeuterio-2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]amino]pyrimidin-4-yl]benzoic acid Chemical compound C(CCC)OC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NC(C([2H])([2H])N1C(=CC2=C(C=CC(=C12)F)OC)C)([2H])[2H])Cl ACMLGOZEKOERDS-LZMSFWOYSA-N 0.000 claims 1
- BTHRJLHUHQYOOG-UHFFFAOYSA-N 2-chloro-4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-6-(2-methylpropoxy)benzoic acid Chemical compound COc1ccc(F)c2n(CCNc3cc(ncn3)-c3cc(Cl)c(C(O)=O)c(OCC(C)C)c3)c(cc12)C#N BTHRJLHUHQYOOG-UHFFFAOYSA-N 0.000 claims 1
- ALNMLNXZBQNHNB-UHFFFAOYSA-N 2-chloro-4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-6-propoxybenzoic acid Chemical compound CCCOc1cc(cc(Cl)c1C(O)=O)-c1cc(NCCn2c(cc3c(OC)ccc(F)c23)C#N)ncn1 ALNMLNXZBQNHNB-UHFFFAOYSA-N 0.000 claims 1
- WETSKNPNXOBOBJ-UHFFFAOYSA-N 2-chloro-4-[6-[2-(4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-propylbenzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC=C12)OC)C)CCC WETSKNPNXOBOBJ-UHFFFAOYSA-N 0.000 claims 1
- XEXPBROMLBYCOF-UHFFFAOYSA-N 2-chloro-4-[6-[2-(5,7-difluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-propoxybenzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C(=CC(=C12)F)F)C)C)OCCC XEXPBROMLBYCOF-UHFFFAOYSA-N 0.000 claims 1
- FTTBMNDUVYAMFK-UHFFFAOYSA-N 2-chloro-4-[6-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-(2,2,2-trifluoroethoxy)benzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C(=C12)F)F)OC)C)OCC(F)(F)F FTTBMNDUVYAMFK-UHFFFAOYSA-N 0.000 claims 1
- OCTWETXPHNJNTO-UHFFFAOYSA-N 2-chloro-4-[6-[2-(6-chloro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-propylbenzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)Cl)OC)C)CCC OCTWETXPHNJNTO-UHFFFAOYSA-N 0.000 claims 1
- WNYVCOASQMUBNB-UHFFFAOYSA-N 2-chloro-4-[6-[2-(6-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-propylbenzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)C)C)CCC WNYVCOASQMUBNB-UHFFFAOYSA-N 0.000 claims 1
- XYVAYQQNTHIBRB-UHFFFAOYSA-N 2-chloro-4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-(2,2,2-trifluoroethoxy)benzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)OC)C)OCC(F)(F)F XYVAYQQNTHIBRB-UHFFFAOYSA-N 0.000 claims 1
- KEZFOYREOWISDE-UHFFFAOYSA-N 2-chloro-4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-(2-methylpropoxy)benzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)OC)C)OCC(C)C KEZFOYREOWISDE-UHFFFAOYSA-N 0.000 claims 1
- RSMHWGULCMSNNO-UHFFFAOYSA-N 2-chloro-4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-propylbenzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)OC)C)CCC RSMHWGULCMSNNO-UHFFFAOYSA-N 0.000 claims 1
- WQPWXXKMVIMTEY-UHFFFAOYSA-N 2-chloro-4-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-propylbenzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)C)C)CCC WQPWXXKMVIMTEY-UHFFFAOYSA-N 0.000 claims 1
- RPPRAEATANDQCP-UHFFFAOYSA-N 2-chloro-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-(2,2,2-trifluoroethoxy)benzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)OCC(F)(F)F RPPRAEATANDQCP-UHFFFAOYSA-N 0.000 claims 1
- YMCKFYMJRMDSOM-UHFFFAOYSA-N 2-chloro-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-(2-methylpropoxy)benzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)OCC(C)C YMCKFYMJRMDSOM-UHFFFAOYSA-N 0.000 claims 1
- OZRYEOJZIKKJEE-UHFFFAOYSA-N 2-chloro-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-propoxybenzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)OCCC OZRYEOJZIKKJEE-UHFFFAOYSA-N 0.000 claims 1
- JDGHJXHCYZJPOJ-UHFFFAOYSA-N 2-chloro-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-propylbenzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)CCC JDGHJXHCYZJPOJ-UHFFFAOYSA-N 0.000 claims 1
- MPZDJBHCHPLXLP-UHFFFAOYSA-N 2-chloro-6-(ethylamino)-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound ClC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)NCC MPZDJBHCHPLXLP-UHFFFAOYSA-N 0.000 claims 1
- KCWUCYWIPDLHCH-UHFFFAOYSA-N 2-cyclobutyloxy-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C KCWUCYWIPDLHCH-UHFFFAOYSA-N 0.000 claims 1
- KDWVAXNSGMKDLI-UHFFFAOYSA-N 2-cyclopentyloxy-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C1(CCCC1)OC1=C(C(=O)O)C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C KDWVAXNSGMKDLI-UHFFFAOYSA-N 0.000 claims 1
- WEQIJMMDAFIZRL-UHFFFAOYSA-N 2-fluoro-4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-propylbenzoic acid Chemical compound FC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)OC)C)CCC WEQIJMMDAFIZRL-UHFFFAOYSA-N 0.000 claims 1
- KBSMAHITAWGUJE-UHFFFAOYSA-N 2-fluoro-4-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-propylbenzoic acid Chemical compound FC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)C)C)CCC KBSMAHITAWGUJE-UHFFFAOYSA-N 0.000 claims 1
- SQQMZNVAPLPNFC-UHFFFAOYSA-N 2-fluoro-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-6-propylbenzoic acid Chemical compound FC1=C(C(=O)O)C(=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)CCC SQQMZNVAPLPNFC-UHFFFAOYSA-N 0.000 claims 1
- USMLYEJRTXYWNB-UHFFFAOYSA-N 3-[2-ethoxy-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-4H-1,2,4-oxadiazol-5-one Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)C1=NOC(N1)=O USMLYEJRTXYWNB-UHFFFAOYSA-N 0.000 claims 1
- GHFOIPGDROLZJW-UHFFFAOYSA-N 3-[3-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-5-ethoxyphenoxy]propanoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C=1C=C(OCCC(=O)O)C=C(C=1)OCC GHFOIPGDROLZJW-UHFFFAOYSA-N 0.000 claims 1
- AYXYLXPSSYURCG-UHFFFAOYSA-N 3-[3-ethoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]-4H-1,2,4-oxadiazol-5-one Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)C1=NOC(N1)=O AYXYLXPSSYURCG-UHFFFAOYSA-N 0.000 claims 1
- DHGKRRWNNHPWPL-UHFFFAOYSA-N 3-[3-ethoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]propanoic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)CCC(=O)O DHGKRRWNNHPWPL-UHFFFAOYSA-N 0.000 claims 1
- GTEBIGCIJKPLDX-UHFFFAOYSA-N 3-[4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxyphenoxy]propanoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(OCCC(=O)O)C=C1)OCC GTEBIGCIJKPLDX-UHFFFAOYSA-N 0.000 claims 1
- KRHWMYKTPOXVOI-UHFFFAOYSA-N 3-[4-[6-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-4H-1,2,4-oxadiazol-5-one Chemical compound FC1=CC(=C2C=C(N(C2=C1F)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)C1=NOC(N1)=O)C)OC KRHWMYKTPOXVOI-UHFFFAOYSA-N 0.000 claims 1
- RPMZAFXIMJYQDN-UHFFFAOYSA-N 3-[4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-4H-1,2,4-oxadiazol-5-one Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)C1=NOC(N1)=O)C)OC RPMZAFXIMJYQDN-UHFFFAOYSA-N 0.000 claims 1
- YLXNFITXMPKMPI-UHFFFAOYSA-N 3-[5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophen-2-yl]propanoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)CCC(=O)O)OCC YLXNFITXMPKMPI-UHFFFAOYSA-N 0.000 claims 1
- LOMQTCNWKQBWRJ-UHFFFAOYSA-N 3-[5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophen-2-yl]-4H-1,2,4-oxadiazol-5-one Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C1=NOC(N1)=O)C(F)(F)F)C)OC LOMQTCNWKQBWRJ-UHFFFAOYSA-N 0.000 claims 1
- IMJGJTBAEDUXKD-UHFFFAOYSA-N 3-[5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-propan-2-yloxythiophen-2-yl]propanoic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)CCC(=O)O)OC(C)C)C)OC IMJGJTBAEDUXKD-UHFFFAOYSA-N 0.000 claims 1
- CEURFFMIOWMVMN-UHFFFAOYSA-N 3-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-5-ethoxybenzoic acid Chemical compound CCOc1cc(cc(c1)-c1cc(NCCn2c(cc3c(OC)ccc(F)c23)C#N)ncn1)C(O)=O CEURFFMIOWMVMN-UHFFFAOYSA-N 0.000 claims 1
- PMMDVYKHXOYQSR-UHFFFAOYSA-N 3-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-5-ethylsulfanylbenzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C=1C=C(C(=O)O)C=C(C=1)SCC PMMDVYKHXOYQSR-UHFFFAOYSA-N 0.000 claims 1
- ZGQFLJDDLYXRMF-UHFFFAOYSA-N 3-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-5-methoxybenzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C=1C=C(C(=O)O)C=C(C=1)OC ZGQFLJDDLYXRMF-UHFFFAOYSA-N 0.000 claims 1
- NLHOTXDEDPAJCJ-UHFFFAOYSA-N 3-butoxy-5-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(CCC)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)OC)C)C(=O)O NLHOTXDEDPAJCJ-UHFFFAOYSA-N 0.000 claims 1
- ZTKHYUIKKIOCIK-UHFFFAOYSA-N 3-butoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(CCC)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)C(=O)O ZTKHYUIKKIOCIK-UHFFFAOYSA-N 0.000 claims 1
- YWLRIFBVFFXKMK-UHFFFAOYSA-N 3-chloro-5-[6-[2-(4-chloro-2-cyano-6,7-difluoroindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound ClC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C(=C12)F)F)Cl)C#N)C(=O)O YWLRIFBVFFXKMK-UHFFFAOYSA-N 0.000 claims 1
- ZDLASRUQLJBZOD-UHFFFAOYSA-N 3-chloro-5-[6-[2-(4-chloro-2-cyanoindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound ClC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC=C12)Cl)C#N)C(=O)O ZDLASRUQLJBZOD-UHFFFAOYSA-N 0.000 claims 1
- GBGLVTIPEYSUJM-UHFFFAOYSA-N 3-chloro-5-[6-[2-(4-chloro-7-fluoro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound ClC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)Cl)C)C(=O)O GBGLVTIPEYSUJM-UHFFFAOYSA-N 0.000 claims 1
- LQJOWOJMLCPQPH-UHFFFAOYSA-N 3-chloro-5-[6-[2-(6-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound ClC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)C)C)C(=O)O LQJOWOJMLCPQPH-UHFFFAOYSA-N 0.000 claims 1
- FAJDIWZKMWWLQI-UHFFFAOYSA-N 3-chloro-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound ClC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)C(=O)O FAJDIWZKMWWLQI-UHFFFAOYSA-N 0.000 claims 1
- GSJTZNLAOMBZDS-UHFFFAOYSA-N 3-ethoxy-5-[6-[1-(7-fluoro-4-methoxy-2-methylindol-1-yl)propan-2-ylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NC(CN1C(=CC2=C(C=CC(=C12)F)OC)C)C)C(=O)O GSJTZNLAOMBZDS-UHFFFAOYSA-N 0.000 claims 1
- ILNDFOOGIZSACO-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(3-fluoro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=C(C2=CC=CC=C12)F)C)C(=O)O ILNDFOOGIZSACO-UHFFFAOYSA-N 0.000 claims 1
- MCHINYRAHFCHRO-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(4,5,7-trifluoro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C(=CC(=C12)F)F)F)C)C(=O)O MCHINYRAHFCHRO-UHFFFAOYSA-N 0.000 claims 1
- LODYCDCTJPGSFL-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(4,6,7-trifluoro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C(=C12)F)F)F)C)C(=O)O LODYCDCTJPGSFL-UHFFFAOYSA-N 0.000 claims 1
- RZROFIRZVREPMF-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(4-methoxy-2,7-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)C)OC)C)C(=O)O RZROFIRZVREPMF-UHFFFAOYSA-N 0.000 claims 1
- AOHUNDAVQYXMOJ-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC=C12)OC)C)C(=O)O AOHUNDAVQYXMOJ-UHFFFAOYSA-N 0.000 claims 1
- XHIASVSBPFIXRS-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(5,6,7-trifluoro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=CC(=C(C(=C12)F)F)F)C)C(=O)O XHIASVSBPFIXRS-UHFFFAOYSA-N 0.000 claims 1
- NCBGHXKELHLHQB-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)C)C)C(=O)O NCBGHXKELHLHQB-UHFFFAOYSA-N 0.000 claims 1
- NGVMWOMUKHSSBS-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)OC)C)C(=O)O NGVMWOMUKHSSBS-UHFFFAOYSA-N 0.000 claims 1
- HVDJAGAGSHWYAP-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)C)C)C(=O)O HVDJAGAGSHWYAP-UHFFFAOYSA-N 0.000 claims 1
- PPOJKOWBUDCJFR-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-fluoro-2,5-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=CC(=CC(=C12)F)C)C)C(=O)O PPOJKOWBUDCJFR-UHFFFAOYSA-N 0.000 claims 1
- ZHGHDASXDPYKQG-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-N'-hydroxythiophene-2-carboximidamide Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)C(=N)NO ZHGHDASXDPYKQG-UHFFFAOYSA-N 0.000 claims 1
- MSTPRPOZRFLIMN-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-N-methylsulfonylthiophene-2-carboxamide Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)C(=O)NS(=O)(=O)C MSTPRPOZRFLIMN-UHFFFAOYSA-N 0.000 claims 1
- HFUZKDYPJMSRBT-UHFFFAOYSA-N 3-ethoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)C(=O)O HFUZKDYPJMSRBT-UHFFFAOYSA-N 0.000 claims 1
- KKRBVBSHCXMXHY-UHFFFAOYSA-N 3-ethyl-5-[6-[2-(4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)C1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC=C12)OC)C)C(=O)O KKRBVBSHCXMXHY-UHFFFAOYSA-N 0.000 claims 1
- UVLJFYNTBTXIOC-UHFFFAOYSA-N 3-ethyl-5-[6-[2-(6-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)C1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)C)C)C(=O)O UVLJFYNTBTXIOC-UHFFFAOYSA-N 0.000 claims 1
- QXQQCUOCNZNHKP-UHFFFAOYSA-N 3-ethyl-5-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)C1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)C)C)C(=O)O QXQQCUOCNZNHKP-UHFFFAOYSA-N 0.000 claims 1
- FRJWAKOUZQPJQZ-UHFFFAOYSA-N 3-ethyl-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound C(C)C1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)C(=O)O FRJWAKOUZQPJQZ-UHFFFAOYSA-N 0.000 claims 1
- JAKPWHBPLDOTFP-UHFFFAOYSA-N 3-fluoro-5-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound FC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)OC)C)C(=O)O JAKPWHBPLDOTFP-UHFFFAOYSA-N 0.000 claims 1
- KJROBQSMBWASFR-UHFFFAOYSA-N 3-fluoro-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxylic acid Chemical compound FC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)C(=O)O KJROBQSMBWASFR-UHFFFAOYSA-N 0.000 claims 1
- OAXINFFHDYJDDA-UHFFFAOYSA-N 4-[4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-1,3-thiazole-2-carboxylic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)C=1N=C(SC=1)C(=O)O)C)OC OAXINFFHDYJDDA-UHFFFAOYSA-N 0.000 claims 1
- YQTXQARORONFFL-UHFFFAOYSA-N 4-[4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-1,3-thiazole-2-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)C=1N=C(SC=1)C(=O)O)C)OC YQTXQARORONFFL-UHFFFAOYSA-N 0.000 claims 1
- LMSXJJQRZWQQKS-UHFFFAOYSA-N 4-[4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-5-methyl-1,3-thiazol-2-amine Chemical compound NC=1SC(=C(N=1)C1=CC=C(C=C1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)C LMSXJJQRZWQQKS-UHFFFAOYSA-N 0.000 claims 1
- ROYLWOGTCUVNOK-UHFFFAOYSA-N 4-[6-[2-(2-cyano-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(methylamino)benzoic acid Chemical compound C(#N)C=1N(C2=CC=CC(=C2C=1)OC)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)NC ROYLWOGTCUVNOK-UHFFFAOYSA-N 0.000 claims 1
- VPKLGGJNBGSYGW-UHFFFAOYSA-N 4-[6-[2-(2-cyano-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethylsulfanylbenzoic acid Chemical compound C(#N)C=1N(C2=CC=CC(=C2C=1)OC)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SCC VPKLGGJNBGSYGW-UHFFFAOYSA-N 0.000 claims 1
- ZJNFUOMGSDFKQD-UHFFFAOYSA-N 4-[6-[2-(2-cyano-6,7-difluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethylsulfanylbenzoic acid Chemical compound C(#N)C=1N(C2=C(C(=CC(=C2C=1)OC)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SCC ZJNFUOMGSDFKQD-UHFFFAOYSA-N 0.000 claims 1
- YYPUKVURRNVPJN-UHFFFAOYSA-N 4-[6-[2-(2-cyano-6,7-difluoro-4-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzoic acid Chemical compound C(#N)C=1N(C2=C(C(=CC(=C2C=1)C)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC YYPUKVURRNVPJN-UHFFFAOYSA-N 0.000 claims 1
- CWKCCNQSHYBDIS-UHFFFAOYSA-N 4-[6-[2-(2-cyano-6-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)benzoic acid Chemical compound C(#N)C=1N(C2=CC(=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CC(C)C CWKCCNQSHYBDIS-UHFFFAOYSA-N 0.000 claims 1
- MFJXXELSMRLCID-UHFFFAOYSA-N 4-[6-[2-(2-cyano-6-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzoic acid Chemical compound C(#N)C=1N(C2=CC(=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC MFJXXELSMRLCID-UHFFFAOYSA-N 0.000 claims 1
- CNWIIJUSESBLER-UHFFFAOYSA-N 4-[6-[2-(2-cyano-6-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethylsulfanylbenzoic acid Chemical compound C(#N)C=1N(C2=CC(=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SCC CNWIIJUSESBLER-UHFFFAOYSA-N 0.000 claims 1
- LCGHXPZIWCDZEL-UHFFFAOYSA-N 4-[6-[2-(2-cyano-6-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-propan-2-ylsulfanylbenzoic acid Chemical compound C(#N)C=1N(C2=CC(=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC(C)C LCGHXPZIWCDZEL-UHFFFAOYSA-N 0.000 claims 1
- YUGHPYNYNOOFQW-UHFFFAOYSA-N 4-[6-[2-(2-cyano-6-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-propylsulfanylbenzoic acid Chemical compound CCCSc1cc(ccc1C(O)=O)-c1cc(NCCn2c(cc3c(OC)cc(F)cc23)C#N)ncn1 YUGHPYNYNOOFQW-UHFFFAOYSA-N 0.000 claims 1
- AKULRZZGRMTRCL-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropoxy)benzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC(C)C AKULRZZGRMTRCL-UHFFFAOYSA-N 0.000 claims 1
- HQFIYJQYLQTGPL-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(difluoromethoxy)benzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OC(F)F HQFIYJQYLQTGPL-UHFFFAOYSA-N 0.000 claims 1
- YOFFPBWNJHATEB-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(methylamino)benzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)NC YOFFPBWNJHATEB-UHFFFAOYSA-N 0.000 claims 1
- VCYUSCRDPRIRDT-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxy-3-fluorobenzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=C(C(=C(C(=O)O)C=C1)OCC)F VCYUSCRDPRIRDT-UHFFFAOYSA-N 0.000 claims 1
- OZHROPMWDDTEBE-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxy-N-hydroxybenzamide Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)NO)C=C1)OCC OZHROPMWDDTEBE-UHFFFAOYSA-N 0.000 claims 1
- KSXVLQRSFLFFHR-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzenesulfonamide Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)S(=O)(=O)N)OCC KSXVLQRSFLFFHR-UHFFFAOYSA-N 0.000 claims 1
- ATHBRSZAGNKLKU-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethylbenzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CC ATHBRSZAGNKLKU-UHFFFAOYSA-N 0.000 claims 1
- LCTNWOMZGJKZSM-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethylsulfanylbenzoic acid Chemical compound CCSc1cc(ccc1C(O)=O)-c1cc(NCCn2c(cc3c(OC)ccc(F)c23)C#N)ncn1 LCTNWOMZGJKZSM-UHFFFAOYSA-N 0.000 claims 1
- QTNXACWYERGRTA-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-fluoro-6-propoxybenzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C(=C1)OCCC)F QTNXACWYERGRTA-UHFFFAOYSA-N 0.000 claims 1
- WHXNVFVAPLXWMX-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-fluoro-6-propylbenzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C(=C1)CCC)F WHXNVFVAPLXWMX-UHFFFAOYSA-N 0.000 claims 1
- BGBCNVQIDKINAW-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-propan-2-ylsulfanylbenzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SC(C)C BGBCNVQIDKINAW-UHFFFAOYSA-N 0.000 claims 1
- SEPAKAYPQUUDTH-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-propoxybenzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCCC SEPAKAYPQUUDTH-UHFFFAOYSA-N 0.000 claims 1
- UJIFYFVJOYIDIW-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-propylbenzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CCC UJIFYFVJOYIDIW-UHFFFAOYSA-N 0.000 claims 1
- ABJXFZNNMJPMQN-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-propylsulfanylbenzoic acid Chemical compound CCCSc1cc(ccc1C(O)=O)-c1cc(NCCn2c(cc3c(OC)ccc(F)c23)C#N)ncn1 ABJXFZNNMJPMQN-UHFFFAOYSA-N 0.000 claims 1
- BQWVKZHMEVVTOL-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-N-(2-methoxyethyl)benzamide Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC=C(C(=O)NCCOC)C=C1 BQWVKZHMEVVTOL-UHFFFAOYSA-N 0.000 claims 1
- XVLFHSPWTTVHLW-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]benzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC=C(C(=O)O)C=C1 XVLFHSPWTTVHLW-UHFFFAOYSA-N 0.000 claims 1
- XZRLLUJLNKACOL-UHFFFAOYSA-N 4-[6-[2-(2-cyano-7-fluoro-4-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethylsulfanylbenzoic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)C)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)SCC XZRLLUJLNKACOL-UHFFFAOYSA-N 0.000 claims 1
- FEMCERWFHYIOGK-UHFFFAOYSA-N 4-[6-[2-(5,7-difluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)benzoic acid Chemical compound FC=1C(=C2C=C(N(C2=C(C=1)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CC(C)C)C)C FEMCERWFHYIOGK-UHFFFAOYSA-N 0.000 claims 1
- CZUDAHWTBTUBCW-UHFFFAOYSA-N 4-[6-[2-(5,7-difluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(methylamino)benzoic acid Chemical compound FC=1C(=C2C=C(N(C2=C(C=1)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)NC)C)C CZUDAHWTBTUBCW-UHFFFAOYSA-N 0.000 claims 1
- KSMKOLYTTKFQPN-UHFFFAOYSA-N 4-[6-[2-(5,7-difluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzoic acid Chemical compound FC=1C(=C2C=C(N(C2=C(C=1)F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC)C)C KSMKOLYTTKFQPN-UHFFFAOYSA-N 0.000 claims 1
- QXSRMTPNTPJRDO-UHFFFAOYSA-N 4-[6-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(2,2,2-trifluoroethylamino)benzoic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)NCC(F)(F)F)C)OC QXSRMTPNTPJRDO-UHFFFAOYSA-N 0.000 claims 1
- ZIHRZFFQDAXKMC-UHFFFAOYSA-N 4-[6-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)benzoic acid Chemical compound COc1cc(F)c(F)c2n(CCNc3cc(ncn3)-c3ccc(C(O)=O)c(CC(C)C)c3)c(C)cc12 ZIHRZFFQDAXKMC-UHFFFAOYSA-N 0.000 claims 1
- DDXNTMHPEKHTKT-UHFFFAOYSA-N 4-[6-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-ethoxybenzoic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC)C)OC DDXNTMHPEKHTKT-UHFFFAOYSA-N 0.000 claims 1
- BEWCYAYZXXYHQD-UHFFFAOYSA-N 4-[6-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-fluoro-6-propoxybenzoic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1F)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C(=C1)OCCC)F)C)OC BEWCYAYZXXYHQD-UHFFFAOYSA-N 0.000 claims 1
- XSEYRFUNRRIGRT-UHFFFAOYSA-N 4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropoxy)benzoic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC(C)C)C)OC XSEYRFUNRRIGRT-UHFFFAOYSA-N 0.000 claims 1
- PLZDCNOIOJNYFH-UHFFFAOYSA-N 4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)benzoic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CC(C)C)C)OC PLZDCNOIOJNYFH-UHFFFAOYSA-N 0.000 claims 1
- XLUJSSVCBYGPBC-UHFFFAOYSA-N 4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(methylamino)benzoic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)NC)C)OC XLUJSSVCBYGPBC-UHFFFAOYSA-N 0.000 claims 1
- ONXVUFWPQNKSJS-UHFFFAOYSA-N 4-[6-[2-(7-chloro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(ethylamino)benzoic acid Chemical compound ClC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)NCC)C)OC ONXVUFWPQNKSJS-UHFFFAOYSA-N 0.000 claims 1
- IJJBCHVCUFBJSF-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropoxy)benzoic acid Chemical compound CC(C)COC1=C(C=CC(=C1)C1=CC(NCCN2C(C)=CC3=C(C)C=CC(F)=C23)=NC=N1)C(O)=O IJJBCHVCUFBJSF-UHFFFAOYSA-N 0.000 claims 1
- YJJXIKWCGHWZOI-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(methylamino)benzoic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)NC)C)C YJJXIKWCGHWZOI-UHFFFAOYSA-N 0.000 claims 1
- YWXMSQILAMPVSR-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]-2-methylpyrimidin-4-yl]-2-(2-methylpropyl)benzoic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC(=N1)C)C1=CC(=C(C(=O)O)C=C1)CC(C)C)C)OC YWXMSQILAMPVSR-UHFFFAOYSA-N 0.000 claims 1
- CLVPYXKPTYKDRF-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropoxy)benzoic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCC(C)C)C)OC CLVPYXKPTYKDRF-UHFFFAOYSA-N 0.000 claims 1
- DMTFYNVELYEDRS-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(2-methylpropyl)benzoic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CC(C)C)C)OC DMTFYNVELYEDRS-UHFFFAOYSA-N 0.000 claims 1
- VSYUEMDKDYAXEF-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(methylamino)benzoic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)NC)C)OC VSYUEMDKDYAXEF-UHFFFAOYSA-N 0.000 claims 1
- NRFZCDSPXVFMEP-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(trifluoromethoxy)phenol Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)O)OC(F)(F)F)C)OC NRFZCDSPXVFMEP-UHFFFAOYSA-N 0.000 claims 1
- ZDPQFZFPIPJFDL-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-(trifluoromethyl)benzenesulfonamide Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)S(=O)(=O)N)C(F)(F)F)C)OC ZDPQFZFPIPJFDL-UHFFFAOYSA-N 0.000 claims 1
- OMTGZEFSRYASMM-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-propoxybenzoic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)OCCC)C)OC OMTGZEFSRYASMM-UHFFFAOYSA-N 0.000 claims 1
- VRNFNNAGRIZQJF-UHFFFAOYSA-N 4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-propylbenzoic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(C(=O)O)C=C1)CCC)C)OC VRNFNNAGRIZQJF-UHFFFAOYSA-N 0.000 claims 1
- FAIDKSOSIQMHSE-UHFFFAOYSA-N 4-ethoxy-2-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-1,3-thiazole-5-carboxylic acid Chemical compound C(C)OC=1N=C(SC=1C(=O)O)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C FAIDKSOSIQMHSE-UHFFFAOYSA-N 0.000 claims 1
- ZEWUXVFLALOJQZ-UHFFFAOYSA-N 5-[3-ethoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]-1,2-oxazol-3-one Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)C1=CC(=NO1)O ZEWUXVFLALOJQZ-UHFFFAOYSA-N 0.000 claims 1
- QHGMFGILSFNPBV-UHFFFAOYSA-N 5-[4-[6-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-1,3-oxazol-2-amine Chemical compound NC=1OC(=CN=1)C1=CC=C(C=C1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=C(C(=C12)F)F)OC)C QHGMFGILSFNPBV-UHFFFAOYSA-N 0.000 claims 1
- YNNNSOPRVFMTEH-UHFFFAOYSA-N 5-[4-[6-[2-(6-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-N-methyl-1,3,4-thiadiazol-2-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C=1SC(=NN=1)NC)C)C YNNNSOPRVFMTEH-UHFFFAOYSA-N 0.000 claims 1
- DSYFAWKSFSGZGR-UHFFFAOYSA-N 5-[4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-1,3-oxazol-2-amine Chemical compound NC=1OC(=CN=1)C1=CC=C(C=C1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=C(C=C12)F)OC)C DSYFAWKSFSGZGR-UHFFFAOYSA-N 0.000 claims 1
- SLNXKCHNBWUYJL-UHFFFAOYSA-N 5-[4-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-N-methyl-1,3,4-thiadiazol-2-amine Chemical compound CNC1=NN=C(S1)C1=CC=C(C=C1)C1=NC=NC(NCCN2C(C)=CC3=C(OC)C=C(F)C=C23)=C1 SLNXKCHNBWUYJL-UHFFFAOYSA-N 0.000 claims 1
- VXNJKXBGEPGDAL-UHFFFAOYSA-N 5-[4-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-N-methyl-1,3,4-thiadiazol-2-amine Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C=1SC(=NN=1)NC)C)C VXNJKXBGEPGDAL-UHFFFAOYSA-N 0.000 claims 1
- PFKRLHKDENAIRO-UHFFFAOYSA-N 5-[4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-1,2-oxazol-3-amine Chemical compound NC1=NOC(=C1)C1=CC=C(C=C1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C PFKRLHKDENAIRO-UHFFFAOYSA-N 0.000 claims 1
- ZBHSANAKCKVPGR-UHFFFAOYSA-N 5-[4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-1,3-oxazol-2-amine Chemical compound NC=1OC(=CN=1)C1=CC=C(C=C1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C ZBHSANAKCKVPGR-UHFFFAOYSA-N 0.000 claims 1
- NFYMCZFJPRVTPL-UHFFFAOYSA-N 5-[4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]-N-methyl-1,3,4-thiadiazol-2-amine Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C=1SC(=NN=1)NC)C)OC NFYMCZFJPRVTPL-UHFFFAOYSA-N 0.000 claims 1
- OSDZAOIEVIGFSC-UHFFFAOYSA-N 5-[6-[2-(2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound CC=1N(C2=CC=CC(=C2C=1)C)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC OSDZAOIEVIGFSC-UHFFFAOYSA-N 0.000 claims 1
- OKUOBKKQYSMFJU-UHFFFAOYSA-N 5-[6-[2-(2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-propan-2-yloxythiophene-2-carboxylic acid Chemical compound CC(C)Oc1cc(sc1C(O)=O)-c1cc(NCCn2c(C)cc3c(C)cccc23)ncn1 OKUOBKKQYSMFJU-UHFFFAOYSA-N 0.000 claims 1
- RFHXNDZOLUFFJL-UHFFFAOYSA-N 5-[6-[2-(2-chloro-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC RFHXNDZOLUFFJL-UHFFFAOYSA-N 0.000 claims 1
- COUAMZKUCYDOEX-UHFFFAOYSA-N 5-[6-[2-(2-cyano-3,7-difluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1F)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F COUAMZKUCYDOEX-UHFFFAOYSA-N 0.000 claims 1
- UTFQCJTXVUDCLH-UHFFFAOYSA-N 5-[6-[2-(2-cyano-3-fluoroindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=CC=CC=C2C=1F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F UTFQCJTXVUDCLH-UHFFFAOYSA-N 0.000 claims 1
- XQIGYUJCCWAQGT-UHFFFAOYSA-N 5-[6-[2-(2-cyano-3-fluoroindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=CC=CC=C2C=1F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC XQIGYUJCCWAQGT-UHFFFAOYSA-N 0.000 claims 1
- UQFWNMWNPUQACR-UHFFFAOYSA-N 5-[6-[2-(2-cyano-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=CC=CC(=C2C=1)OC)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F UQFWNMWNPUQACR-UHFFFAOYSA-N 0.000 claims 1
- JUBIHEUOBOWJNK-UHFFFAOYSA-N 5-[6-[2-(2-cyano-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=CC=CC(=C2C=1)OC)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC JUBIHEUOBOWJNK-UHFFFAOYSA-N 0.000 claims 1
- FCPULIFDLODXRA-UHFFFAOYSA-N 5-[6-[2-(2-cyano-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-fluorothiophene-2-carboxylic acid Chemical compound COc1cccc2n(CCNc3cc(ncn3)-c3cc(F)c(s3)C(O)=O)c(cc12)C#N FCPULIFDLODXRA-UHFFFAOYSA-N 0.000 claims 1
- RFIGWDWUQKAGPD-UHFFFAOYSA-N 5-[6-[2-(2-cyano-5,6-difluoro-4-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=CC(=C(C(=C2C=1)C)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC RFIGWDWUQKAGPD-UHFFFAOYSA-N 0.000 claims 1
- YFNRVTIRDMSVJB-UHFFFAOYSA-N 5-[6-[2-(2-cyano-5,7-difluoro-4-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=C(C(=C2C=1)C)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC YFNRVTIRDMSVJB-UHFFFAOYSA-N 0.000 claims 1
- FNZKRECBUDVKGZ-UHFFFAOYSA-N 5-[6-[2-(2-cyano-6,7-difluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C(=CC(=C2C=1)OC)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC FNZKRECBUDVKGZ-UHFFFAOYSA-N 0.000 claims 1
- BFXXFPIGWUTYQN-UHFFFAOYSA-N 5-[6-[2-(2-cyano-6,7-difluoro-4-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C(=CC(=C2C=1)C)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC BFXXFPIGWUTYQN-UHFFFAOYSA-N 0.000 claims 1
- PARNQHFBLKEYFQ-UHFFFAOYSA-N 5-[6-[2-(2-cyano-6-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=CC(=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC PARNQHFBLKEYFQ-UHFFFAOYSA-N 0.000 claims 1
- TWCZCAPATOVSEH-UHFFFAOYSA-N 5-[6-[2-(2-cyano-6-fluoro-4-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=CC(=CC(=C2C=1)C)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC TWCZCAPATOVSEH-UHFFFAOYSA-N 0.000 claims 1
- UUTNZKJBQUYCRF-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F UUTNZKJBQUYCRF-UHFFFAOYSA-N 0.000 claims 1
- YUKHECKRGAOLLC-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxy-N,N-dimethylthiophene-2-carboxamide Chemical compound CN(C(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N)C YUKHECKRGAOLLC-UHFFFAOYSA-N 0.000 claims 1
- KISATXALXHPRTM-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxy-N-(2-hydroxyethyl)thiophene-2-carboxamide Chemical compound OCCNC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N KISATXALXHPRTM-UHFFFAOYSA-N 0.000 claims 1
- ITKFVROZAZMOHQ-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxy-N-(2-methoxyethyl)thiophene-2-carboxamide Chemical compound COCCNC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N ITKFVROZAZMOHQ-UHFFFAOYSA-N 0.000 claims 1
- JOPTUNYTZLNBKE-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxy-N-ethylsulfonylthiophene-2-carboxamide Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)NS(=O)(=O)CC)OCC JOPTUNYTZLNBKE-UHFFFAOYSA-N 0.000 claims 1
- IOCWJRLTRBQTEQ-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxy-N-ethylthiophene-2-carboxamide Chemical compound C(C)NC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N IOCWJRLTRBQTEQ-UHFFFAOYSA-N 0.000 claims 1
- WJAAQSUJJCRRRF-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxy-N-hydroxythiophene-2-carboxamide Chemical compound ONC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N WJAAQSUJJCRRRF-UHFFFAOYSA-N 0.000 claims 1
- HSEIYPBHTLTYLH-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxy-N-methylsulfonylthiophene-2-carboxamide Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)NS(=O)(=O)C)OCC HSEIYPBHTLTYLH-UHFFFAOYSA-N 0.000 claims 1
- IZRSWPXCDCQJRK-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxy-N-methylthiophene-2-carboxamide Chemical compound CNC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N IZRSWPXCDCQJRK-UHFFFAOYSA-N 0.000 claims 1
- WQZDZIZIXLPQEL-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxy-N-propan-2-ylsulfonylthiophene-2-carboxamide Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)NS(=O)(=O)C(C)C)OCC WQZDZIZIXLPQEL-UHFFFAOYSA-N 0.000 claims 1
- HHYJQFBIAVXYPS-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxy-N-propan-2-ylthiophene-2-carboxamide Chemical compound C(C)(C)NC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N HHYJQFBIAVXYPS-UHFFFAOYSA-N 0.000 claims 1
- ZCXCRKDJOGGYKK-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxy-N-sulfamoylthiophene-2-carboxamide Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)NS(N)(=O)=O)OCC ZCXCRKDJOGGYKK-UHFFFAOYSA-N 0.000 claims 1
- UIRRBSPUIYGBOF-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC UIRRBSPUIYGBOF-UHFFFAOYSA-N 0.000 claims 1
- QDEUHPKOKNQRQG-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-fluorothiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)F QDEUHPKOKNQRQG-UHFFFAOYSA-N 0.000 claims 1
- QJSNBTYXZIFGID-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-propan-2-yloxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OC(C)C QJSNBTYXZIFGID-UHFFFAOYSA-N 0.000 claims 1
- AAXKQOQFHARQGH-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-N-cyclopropylsulfonyl-3-ethoxythiophene-2-carboxamide Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)NS(=O)(=O)C1CC1)OCC AAXKQOQFHARQGH-UHFFFAOYSA-N 0.000 claims 1
- PSJPCMPJGFZYFI-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-2-carboxamide Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC=C(S1)C(=O)N PSJPCMPJGFZYFI-UHFFFAOYSA-N 0.000 claims 1
- KOQGKODMRKPUPU-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)C)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F KOQGKODMRKPUPU-UHFFFAOYSA-N 0.000 claims 1
- JAESZDDXEPOENQ-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)C)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC JAESZDDXEPOENQ-UHFFFAOYSA-N 0.000 claims 1
- IONWMQVCIPJBLO-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoro-4-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-fluorothiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)C)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)F IONWMQVCIPJBLO-UHFFFAOYSA-N 0.000 claims 1
- NLXIQMOXVCEAKW-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoroindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=CC=C2C=1)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F NLXIQMOXVCEAKW-UHFFFAOYSA-N 0.000 claims 1
- ZFNUSHSRIPFKKQ-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoroindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=CC=C2C=1)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC ZFNUSHSRIPFKKQ-UHFFFAOYSA-N 0.000 claims 1
- QEGUMSTWTPGHNS-UHFFFAOYSA-N 5-[6-[2-(2-cyano-7-fluoroindol-1-yl)ethylamino]pyrimidin-4-yl]-3-fluorothiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=C(C=CC=C2C=1)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)F QEGUMSTWTPGHNS-UHFFFAOYSA-N 0.000 claims 1
- ZVPVHJUGAJRSKA-UHFFFAOYSA-N 5-[6-[2-(2-cyanoindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound C(#N)C=1N(C2=CC=CC=C2C=1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC ZVPVHJUGAJRSKA-UHFFFAOYSA-N 0.000 claims 1
- MOOPDTLRVZPSMO-UHFFFAOYSA-N 5-[6-[2-(3,7-difluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound FC1=C(N(C2=C(C=CC(=C12)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C MOOPDTLRVZPSMO-UHFFFAOYSA-N 0.000 claims 1
- DIQXBAROJBNMSB-UHFFFAOYSA-N 5-[6-[2-(4,5-difluoro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound FC1=C2C=C(N(C2=CC=C1F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C DIQXBAROJBNMSB-UHFFFAOYSA-N 0.000 claims 1
- JSZFCBWAYRCWAB-UHFFFAOYSA-N 5-[6-[2-(4,6-dichloro-2-cyanoindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=CC(=C1)Cl)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F)C#N JSZFCBWAYRCWAB-UHFFFAOYSA-N 0.000 claims 1
- JBTQVOUBJVAQPI-UHFFFAOYSA-N 5-[6-[2-(4,6-dichloro-2-cyanoindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound CCOc1cc(sc1C(O)=O)-c1cc(NCCn2c(cc3c(Cl)cc(Cl)cc23)C#N)ncn1 JBTQVOUBJVAQPI-UHFFFAOYSA-N 0.000 claims 1
- CSWIKVDGZIMDAF-UHFFFAOYSA-N 5-[6-[2-(4,6-dichloro-2-cyanoindol-1-yl)ethylamino]pyrimidin-4-yl]-3-fluorothiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=CC(=C1)Cl)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)F)C#N CSWIKVDGZIMDAF-UHFFFAOYSA-N 0.000 claims 1
- BSWWXWPCBMQPLA-UHFFFAOYSA-N 5-[6-[2-(4,6-dichloro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=CC(=C1)Cl)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C BSWWXWPCBMQPLA-UHFFFAOYSA-N 0.000 claims 1
- CQZNVXAVJWGOGJ-UHFFFAOYSA-N 5-[6-[2-(4,6-dichloro-7-fluoro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=C(C(=C1)Cl)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C CQZNVXAVJWGOGJ-UHFFFAOYSA-N 0.000 claims 1
- LRYLSJNEXXVWOJ-UHFFFAOYSA-N 5-[6-[2-(4,7-dichloro-5-fluoro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=C(C=C1F)Cl)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C LRYLSJNEXXVWOJ-UHFFFAOYSA-N 0.000 claims 1
- DETFWVMFSMJQQK-UHFFFAOYSA-N 5-[6-[2-(4-bromo-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound BrC1=C2C=C(N(C2=CC=C1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C DETFWVMFSMJQQK-UHFFFAOYSA-N 0.000 claims 1
- IKEWHPOLIGSCKJ-UHFFFAOYSA-N 5-[6-[2-(4-chloro-2-cyano-6,7-difluoroindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=C(C(=C1)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F)C#N IKEWHPOLIGSCKJ-UHFFFAOYSA-N 0.000 claims 1
- ONNMXZZRWVMENB-UHFFFAOYSA-N 5-[6-[2-(4-chloro-2-cyano-6,7-difluoroindol-1-yl)ethylamino]pyrimidin-4-yl]-3-fluorothiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=C(C(=C1)F)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)F)C#N ONNMXZZRWVMENB-UHFFFAOYSA-N 0.000 claims 1
- QLPLPUNLJFVHQQ-UHFFFAOYSA-N 5-[6-[2-(4-chloro-2-cyanoindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=CC=C1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F)C#N QLPLPUNLJFVHQQ-UHFFFAOYSA-N 0.000 claims 1
- YEABTESXFSMIKU-UHFFFAOYSA-N 5-[6-[2-(4-chloro-2-cyanoindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=CC=C1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C#N YEABTESXFSMIKU-UHFFFAOYSA-N 0.000 claims 1
- FAWFQEJLOGRYDE-UHFFFAOYSA-N 5-[6-[2-(4-chloro-2-cyanoindol-1-yl)ethylamino]pyrimidin-4-yl]-3-fluorothiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=CC=C1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)F)C#N FAWFQEJLOGRYDE-UHFFFAOYSA-N 0.000 claims 1
- RMEBCQKRWPHROE-UHFFFAOYSA-N 5-[6-[2-(4-chloro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=CC=C1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C RMEBCQKRWPHROE-UHFFFAOYSA-N 0.000 claims 1
- HHLVTWJAYMJBDI-UHFFFAOYSA-N 5-[6-[2-(4-chloro-6-fluoro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=CC(=C1)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C HHLVTWJAYMJBDI-UHFFFAOYSA-N 0.000 claims 1
- FPRNJIYAJLTXCU-UHFFFAOYSA-N 5-[6-[2-(4-chloro-7-fluoro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=C2C=C(N(C2=C(C=C1)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C FPRNJIYAJLTXCU-UHFFFAOYSA-N 0.000 claims 1
- QXGAHTNJZYSIEY-UHFFFAOYSA-N 5-[6-[2-(5,7-difluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound FC=1C(=C2C=C(N(C2=C(C=1)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C)C QXGAHTNJZYSIEY-UHFFFAOYSA-N 0.000 claims 1
- YFSDVGHUVRCXIH-UHFFFAOYSA-N 5-[6-[2-(5-chloro-7-fluoro-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC=1C=C2C=C(N(C2=C(C=1)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C YFSDVGHUVRCXIH-UHFFFAOYSA-N 0.000 claims 1
- NGTPIBQBNRUQKC-UHFFFAOYSA-N 5-[6-[2-(6,7-difluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C)C NGTPIBQBNRUQKC-UHFFFAOYSA-N 0.000 claims 1
- INVYHOGMOPESTC-UHFFFAOYSA-N 5-[6-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F)C)OC INVYHOGMOPESTC-UHFFFAOYSA-N 0.000 claims 1
- UWHGXICHPWKBNU-UHFFFAOYSA-N 5-[6-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C)OC UWHGXICHPWKBNU-UHFFFAOYSA-N 0.000 claims 1
- MPIOEMUITFWFSB-UHFFFAOYSA-N 5-[6-[2-(6-chloro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound CCOc1cc(sc1C(O)=O)-c1cc(NCCn2c(C)cc3c(C)cc(Cl)cc23)ncn1 MPIOEMUITFWFSB-UHFFFAOYSA-N 0.000 claims 1
- CDTCGSRXUQLKGQ-UHFFFAOYSA-N 5-[6-[2-(6-chloro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C)OC CDTCGSRXUQLKGQ-UHFFFAOYSA-N 0.000 claims 1
- YPNSJBPCKLNBBH-UHFFFAOYSA-N 5-[6-[2-(6-chloro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-propan-2-yloxythiophene-2-carboxylic acid Chemical compound ClC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OC(C)C)C)OC YPNSJBPCKLNBBH-UHFFFAOYSA-N 0.000 claims 1
- KHCNAGQNJLSBBR-UHFFFAOYSA-N 5-[6-[2-(6-chloro-7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC1=CC(=C2C=C(N(C2=C1F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C)OC KHCNAGQNJLSBBR-UHFFFAOYSA-N 0.000 claims 1
- MZHAOWQSLWFAQO-UHFFFAOYSA-N 5-[6-[2-(6-fluoro-2,4-dimethylindol-1-yl)ethylamino]-2-methylpyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC(=N1)C)C1=CC(=C(S1)C(=O)O)C(F)(F)F)C)C MZHAOWQSLWFAQO-UHFFFAOYSA-N 0.000 claims 1
- DPTIRSQPTTWMHK-UHFFFAOYSA-N 5-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]-2-methylpyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC(=N1)C)C1=CC(=C(S1)C(=O)O)C(F)(F)F)C)OC DPTIRSQPTTWMHK-UHFFFAOYSA-N 0.000 claims 1
- GCAUDLRRQRDLAV-UHFFFAOYSA-N 5-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F)C)OC GCAUDLRRQRDLAV-UHFFFAOYSA-N 0.000 claims 1
- HLEOYDZXJGAMCL-UHFFFAOYSA-N 5-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-hydroxythiophene-2-carboxylic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)O)C)OC HLEOYDZXJGAMCL-UHFFFAOYSA-N 0.000 claims 1
- QDPXXBXBGUPAJF-UHFFFAOYSA-N 5-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-propan-2-yloxythiophene-2-carboxylic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OC(C)C)C)OC QDPXXBXBGUPAJF-UHFFFAOYSA-N 0.000 claims 1
- WGQGJMZYVJNVQD-UHFFFAOYSA-N 5-[6-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-propoxythiophene-2-carboxylic acid Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCCC)C)OC WGQGJMZYVJNVQD-UHFFFAOYSA-N 0.000 claims 1
- UHNKGTZYVOOJBT-UHFFFAOYSA-N 5-[6-[2-(7-chloro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C)OC UHNKGTZYVOOJBT-UHFFFAOYSA-N 0.000 claims 1
- WCRHDACPIMEFBV-UHFFFAOYSA-N 5-[6-[2-(7-chloro-5-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC=1C=C(C(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C)C)F WCRHDACPIMEFBV-UHFFFAOYSA-N 0.000 claims 1
- CMLQZEZYVDMFNE-UHFFFAOYSA-N 5-[6-[2-(7-chloro-5-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylic acid Chemical compound ClC=1C=C(C(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC)C)OC)F CMLQZEZYVDMFNE-UHFFFAOYSA-N 0.000 claims 1
- KCLORJOWSMSSFD-UHFFFAOYSA-N 5-[6-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-methylthiophene-2-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C)C)C KCLORJOWSMSSFD-UHFFFAOYSA-N 0.000 claims 1
- MGBUYHOICJBHTN-UHFFFAOYSA-N 5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]-2-methylpyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC(=N1)C)C1=CC(=C(S1)C(=O)O)C(F)(F)F)C)OC MGBUYHOICJBHTN-UHFFFAOYSA-N 0.000 claims 1
- ADYOJETVSAWXCT-UHFFFAOYSA-N 5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(2,2,2-trifluoroethoxy)thiophene-2-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCC(F)(F)F)C)OC ADYOJETVSAWXCT-UHFFFAOYSA-N 0.000 claims 1
- GBWVLYGNPULYEL-UHFFFAOYSA-N 5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-(trifluoromethyl)thiophene-2-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C(F)(F)F)C)OC GBWVLYGNPULYEL-UHFFFAOYSA-N 0.000 claims 1
- SOHZTCCGQMPXLN-UHFFFAOYSA-N 5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-hydroxythiophene-2-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)O)C)OC SOHZTCCGQMPXLN-UHFFFAOYSA-N 0.000 claims 1
- GXZXLEREBNBXKA-UHFFFAOYSA-N 5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-methylthiophene-2-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C)C)OC GXZXLEREBNBXKA-UHFFFAOYSA-N 0.000 claims 1
- KSWPAMCUKWMZKE-UHFFFAOYSA-N 5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-propan-2-yloxythiophene-2-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OC(C)C)C)OC KSWPAMCUKWMZKE-UHFFFAOYSA-N 0.000 claims 1
- YVJTVFNCJNACLC-UHFFFAOYSA-N 5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-propoxythiophene-2-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)OCCC)C)OC YVJTVFNCJNACLC-UHFFFAOYSA-N 0.000 claims 1
- FCQILTNYQQOGJN-UHFFFAOYSA-N 5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-3-pyridin-2-ylthiophene-2-carboxylic acid Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)O)C1=NC=CC=C1)C)OC FCQILTNYQQOGJN-UHFFFAOYSA-N 0.000 claims 1
- TVLSNDIZIOXRFD-UHFFFAOYSA-N 5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-N'-hydroxy-3-(trifluoromethyl)thiophene-2-carboximidamide Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=N)NO)C(F)(F)F)C)OC TVLSNDIZIOXRFD-UHFFFAOYSA-N 0.000 claims 1
- GECDIBYJVPCQRY-UHFFFAOYSA-N 6-[3-(ethylamino)-4-(2H-tetrazol-5-yl)phenyl]-N-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethyl]pyrimidin-4-amine Chemical compound C(C)NC=1C=C(C=CC=1C1=NN=NN1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)C)C GECDIBYJVPCQRY-UHFFFAOYSA-N 0.000 claims 1
- JZZRUXGOUNWCPD-UHFFFAOYSA-N 6-[3-(ethylamino)-4-(2H-tetrazol-5-yl)phenyl]-N-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]pyrimidin-4-amine Chemical compound C(C)NC=1C=C(C=CC=1C1=NN=NN1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C JZZRUXGOUNWCPD-UHFFFAOYSA-N 0.000 claims 1
- WDMOZLVTEGAGFM-UHFFFAOYSA-N 6-[3-ethoxy-4-(2H-tetrazol-5-yl)phenyl]-N-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethyl]pyrimidin-4-amine Chemical compound C(C)OC=1C=C(C=CC=1C1=NN=NN1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)C)C WDMOZLVTEGAGFM-UHFFFAOYSA-N 0.000 claims 1
- XBGNNRCDPOUOQX-UHFFFAOYSA-N 6-[3-ethoxy-4-(2H-tetrazol-5-yl)phenyl]-N-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]pyrimidin-4-amine Chemical compound C(C)OC=1C=C(C=CC=1C1=NN=NN1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C XBGNNRCDPOUOQX-UHFFFAOYSA-N 0.000 claims 1
- CBFFBDUUQFZCDS-UHFFFAOYSA-N 6-[4-(1H-imidazol-5-yl)phenyl]-N-[2-(4-methoxy-2-methylindol-1-yl)ethyl]pyrimidin-4-amine Chemical compound N1C=NC(=C1)C1=CC=C(C=C1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC=C12)OC)C CBFFBDUUQFZCDS-UHFFFAOYSA-N 0.000 claims 1
- PQBYBRZUYUSABA-UHFFFAOYSA-N 6-[4-(ethylamino)thiophen-2-yl]-N-[2-(6-fluoro-2,4-dimethylindol-1-yl)ethyl]pyrimidin-4-amine Chemical compound C(C)NC=1C=C(SC=1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=C(C=C12)F)C)C PQBYBRZUYUSABA-UHFFFAOYSA-N 0.000 claims 1
- MGELTSBIEHUASY-UHFFFAOYSA-N 6-[4-(ethylamino)thiophen-2-yl]-N-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]pyrimidin-4-amine Chemical compound C(C)NC=1C=C(SC=1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=C(C=C12)F)OC)C MGELTSBIEHUASY-UHFFFAOYSA-N 0.000 claims 1
- TZFNYHBQBPTDCY-UHFFFAOYSA-N 6-[4-(ethylamino)thiophen-2-yl]-N-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethyl]pyrimidin-4-amine Chemical compound C(C)NC=1C=C(SC=1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)C)C TZFNYHBQBPTDCY-UHFFFAOYSA-N 0.000 claims 1
- QDLAEIZAFVDNRZ-UHFFFAOYSA-N 6-[4-ethoxy-5-(2H-tetrazol-5-yl)thiophen-2-yl]-N-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]pyrimidin-4-amine Chemical compound C(C)OC=1C=C(SC=1C1=NN=NN1)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C QDLAEIZAFVDNRZ-UHFFFAOYSA-N 0.000 claims 1
- RFPFXSOFPPHLHA-UHFFFAOYSA-N 6-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-1,2-dihydroindazol-3-one Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC=C2C(NNC2=C1)=O)C)OC RFPFXSOFPPHLHA-UHFFFAOYSA-N 0.000 claims 1
- HZSFOSYNCXMIHR-UHFFFAOYSA-N 7-fluoro-1-[2-[(6-imidazo[1,2-a]pyridin-6-ylpyrimidin-4-yl)amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1C=CC=2N(C=1)C=CN=2)C#N)OC HZSFOSYNCXMIHR-UHFFFAOYSA-N 0.000 claims 1
- OYEYLYYMIDEQTN-UHFFFAOYSA-N 7-fluoro-1-[2-[[6-(1H-indazol-5-yl)pyrimidin-4-yl]amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound COC1=C2C=C(C#N)N(CCNC3=CC(=NC=N3)C3=CC4=C(NN=C4)C=C3)C2=C(F)C=C1 OYEYLYYMIDEQTN-UHFFFAOYSA-N 0.000 claims 1
- USKFRTAIUYMQSM-UHFFFAOYSA-N 7-fluoro-1-[2-[[6-(1H-indol-2-yl)pyrimidin-4-yl]amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1NC2=CC=CC=C2C=1)C#N)OC USKFRTAIUYMQSM-UHFFFAOYSA-N 0.000 claims 1
- HGNNMWWWRHEDJE-UHFFFAOYSA-N 7-fluoro-1-[2-[[6-(1H-indol-3-yl)pyrimidin-4-yl]amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CNC2=CC=CC=C12)C#N)OC HGNNMWWWRHEDJE-UHFFFAOYSA-N 0.000 claims 1
- CZDAUBZAUIFLSM-UHFFFAOYSA-N 7-fluoro-1-[2-[[6-(1H-indol-5-yl)pyrimidin-4-yl]amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1C=C2C=CNC2=CC=1)C#N)OC CZDAUBZAUIFLSM-UHFFFAOYSA-N 0.000 claims 1
- JUJILOMCMCIWIU-UHFFFAOYSA-N 7-fluoro-1-[2-[[6-(1H-indol-6-yl)pyrimidin-4-yl]amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C2C=CNC2=C1)C#N)OC JUJILOMCMCIWIU-UHFFFAOYSA-N 0.000 claims 1
- INVPONZRVHWMJS-UHFFFAOYSA-N 7-fluoro-1-[2-[[6-[4-(1H-imidazol-5-yl)-3-methoxyphenyl]pyrimidin-4-yl]amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC(=C(C=C1)C=1N=CNC=1)OC)C#N)OC INVPONZRVHWMJS-UHFFFAOYSA-N 0.000 claims 1
- NUJGSAXAYHXEBO-UHFFFAOYSA-N 7-fluoro-1-[2-[[6-[4-(1H-imidazol-5-yl)phenyl]pyrimidin-4-yl]amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C=1NC=NC=1)C#N)OC NUJGSAXAYHXEBO-UHFFFAOYSA-N 0.000 claims 1
- KBXVVGMANXBEEL-UHFFFAOYSA-N 7-fluoro-1-[2-[[6-[4-(2-hydroxy-3,4-dioxocyclobuten-1-yl)phenyl]pyrimidin-4-yl]amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C1=C(C(C1=O)=O)O)C#N)OC KBXVVGMANXBEEL-UHFFFAOYSA-N 0.000 claims 1
- NHOCQHSBINLPOV-UHFFFAOYSA-N 7-fluoro-1-[2-[[6-[4-(2-hydroxyethoxy)phenyl]pyrimidin-4-yl]amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)OCCO)C#N)OC NHOCQHSBINLPOV-UHFFFAOYSA-N 0.000 claims 1
- NKHQUYVYXVHXEO-UHFFFAOYSA-N 7-fluoro-1-[2-[[6-[4-hydroxy-3-(trifluoromethoxy)phenyl]pyrimidin-4-yl]amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC(=C(C=C1)O)OC(F)(F)F)C#N)OC NKHQUYVYXVHXEO-UHFFFAOYSA-N 0.000 claims 1
- QEEUVLOFODSKOE-UHFFFAOYSA-N 7-fluoro-1-[2-[[6-[4-hydroxy-3-(trifluoromethyl)phenyl]pyrimidin-4-yl]amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC(=C(C=C1)O)C(F)(F)F)C#N)OC QEEUVLOFODSKOE-UHFFFAOYSA-N 0.000 claims 1
- IDHYXEWBTITZRC-UHFFFAOYSA-N 7-fluoro-1-[2-[[6-[5-(3-hydroxyoxetan-3-yl)-4-methoxythiophen-2-yl]pyrimidin-4-yl]amino]ethyl]-4-methoxyindole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1SC(=C(C=1)OC)C1(COC1)O)C#N)OC IDHYXEWBTITZRC-UHFFFAOYSA-N 0.000 claims 1
- IQFGMRBMYCRRPP-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(1-methyl-2-oxo-3,4-dihydroquinazolin-7-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C2CNC(N(C2=C1)C)=O)C#N)OC IQFGMRBMYCRRPP-UHFFFAOYSA-N 0.000 claims 1
- AFZUXHNFAHYBAP-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(1-methyl-3-oxo-2H-indazol-6-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C2C(NN(C2=C1)C)=O)C#N)OC AFZUXHNFAHYBAP-UHFFFAOYSA-N 0.000 claims 1
- APSKEXRDNCVNGI-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(1-methylpyrrolo[2,3-b]pyridin-5-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1C=C2C(=NC=1)N(C=C2)C)C#N)OC APSKEXRDNCVNGI-UHFFFAOYSA-N 0.000 claims 1
- JXRZBXUOJTXPSU-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(1-oxo-3,4-dihydro-2H-isoquinolin-6-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1C=C2CCNC(C2=CC=1)=O)C#N)OC JXRZBXUOJTXPSU-UHFFFAOYSA-N 0.000 claims 1
- HOTOZDWJGMAFDB-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CNC2=NC=CC=C21)C#N)OC HOTOZDWJGMAFDB-UHFFFAOYSA-N 0.000 claims 1
- BQJQFJJHELFUFN-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1C=C2C(=NC=1)NC=C2)C#N)OC BQJQFJJHELFUFN-UHFFFAOYSA-N 0.000 claims 1
- WSGGBVWIZPZUEC-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(1H-pyrrolo[2,3-c]pyridin-3-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CNC2=CN=CC=C21)C#N)OC WSGGBVWIZPZUEC-UHFFFAOYSA-N 0.000 claims 1
- WTZJQZCHSQBMOW-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(2-methyl-3-oxo-1H-indazol-6-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C2C(N(NC2=C1)C)=O)C#N)OC WTZJQZCHSQBMOW-UHFFFAOYSA-N 0.000 claims 1
- MDMZNMQZRNIGBQ-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(2-oxo-3,4-dihydro-1H-quinazolin-6-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound COC1=C2C=C(C#N)N(CCNC3=CC(=NC=N3)C3=CC=C4NC(=O)NCC4=C3)C2=C(F)C=C1 MDMZNMQZRNIGBQ-UHFFFAOYSA-N 0.000 claims 1
- GVOWWGIBVFIIFE-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(2-oxo-3H-1,3-benzoxazol-6-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC2=C(NC(O2)=O)C=C1)C#N)OC GVOWWGIBVFIIFE-UHFFFAOYSA-N 0.000 claims 1
- CRCICITWPDCGFX-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(3-methoxy-1H-indazol-6-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C2C(=NNC2=C1)OC)C#N)OC CRCICITWPDCGFX-UHFFFAOYSA-N 0.000 claims 1
- YMJIWGBDPWUFOI-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1C=CC2=C(N(C(O2)=O)C)C=1)C#N)OC YMJIWGBDPWUFOI-UHFFFAOYSA-N 0.000 claims 1
- NQZPVCBCAWCWLS-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-[2-(trifluoromethyl)pyridin-4-yl]pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound COc1ccc(F)c2n(CCNc3cc(ncn3)-c3ccnc(c3)C(F)(F)F)c(cc12)C#N NQZPVCBCAWCWLS-UHFFFAOYSA-N 0.000 claims 1
- UOSZSPWXFYXGNS-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-[3-methoxy-4-(3-oxo-1,2-oxazol-5-yl)phenyl]pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC(=C(C=C1)C1=CC(=NO1)O)OC)C#N)OC UOSZSPWXFYXGNS-UHFFFAOYSA-N 0.000 claims 1
- ACQRSEKYCSXVBZ-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-[4-(2H-triazol-4-yl)phenyl]pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C=1NN=NC=1)C#N)OC ACQRSEKYCSXVBZ-UHFFFAOYSA-N 0.000 claims 1
- RANYKVMEHINBPB-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-[4-(3-oxo-1,2,4-oxadiazol-5-yl)phenyl]pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C1=NC(NO1)=O)C#N)OC RANYKVMEHINBPB-UHFFFAOYSA-N 0.000 claims 1
- QFQZTHYPTHALQP-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-[4-(3-oxo-1,2-oxazol-5-yl)phenyl]pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C1=CC(=NO1)O)C#N)OC QFQZTHYPTHALQP-UHFFFAOYSA-N 0.000 claims 1
- ZBQSVKKAFFYMHA-UHFFFAOYSA-N 7-fluoro-4-methoxy-1-[2-[[6-[4-(5-methyl-1H-imidazol-4-yl)phenyl]pyrimidin-4-yl]amino]ethyl]indole-2-carbonitrile Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C=1N=CNC=1C)C#N)OC ZBQSVKKAFFYMHA-UHFFFAOYSA-N 0.000 claims 1
- 239000005711 Benzoic acid Substances 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- ICJQJAJGHPRQKT-UHFFFAOYSA-N C(C)C=1C=C(C=CC=1O)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N Chemical compound C(C)C=1C=C(C=CC=1O)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N ICJQJAJGHPRQKT-UHFFFAOYSA-N 0.000 claims 1
- WOVQIURIMMOEOL-UHFFFAOYSA-N C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)C)C)C1=NOC(N1)=O Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=C(C=C12)F)C)C)C1=NOC(N1)=O WOVQIURIMMOEOL-UHFFFAOYSA-N 0.000 claims 1
- IJZWQAMTRCYSIX-UHFFFAOYSA-N C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC=C12)OC)C)C1=NOC(N1)=O Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC=C12)OC)C)C1=NOC(N1)=O IJZWQAMTRCYSIX-UHFFFAOYSA-N 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- AQUQVFMRMSBQFP-UHFFFAOYSA-N ClC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)C1=NOC(N1)=O)C)OC Chemical compound ClC1=CC(=C2C=C(N(C2=C1)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)C1=NOC(N1)=O)C)OC AQUQVFMRMSBQFP-UHFFFAOYSA-N 0.000 claims 1
- MZLAFRKUXYWMFS-UHFFFAOYSA-N ClC=1C=C(C=CC=1O)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N Chemical compound ClC=1C=C(C=CC=1O)C1=CC(=NC=N1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N MZLAFRKUXYWMFS-UHFFFAOYSA-N 0.000 claims 1
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- DLVHAWSZHSWRRZ-UHFFFAOYSA-N N-(benzenesulfonyl)-5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxamide Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC(=C(S1)C(=O)NS(=O)(=O)C1=CC=CC=C1)OCC DLVHAWSZHSWRRZ-UHFFFAOYSA-N 0.000 claims 1
- LIFACAFJSFWAMX-UHFFFAOYSA-N N-[2-(4-methoxy-2-methylindol-1-yl)ethyl]-6-[4-(1H-pyrazol-5-yl)phenyl]pyrimidin-4-amine Chemical compound COC1=C2C=C(N(C2=CC=C1)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C=1NN=CC=1)C LIFACAFJSFWAMX-UHFFFAOYSA-N 0.000 claims 1
- ZDGLDUXWVCSXKG-UHFFFAOYSA-N N-[2-(5-chloro-7-methyl-[1,3]dioxolo[4,5-e]indol-6-yl)ethyl]-6-[3-(ethylamino)-4-(2H-tetrazol-5-yl)phenyl]pyrimidin-4-amine Chemical compound ClC=1C=C2C(=C3C=C(N(C=13)CCNC1=NC=NC(=C1)C1=CC(=C(C=C1)C1=NN=NN1)NCC)C)OCO2 ZDGLDUXWVCSXKG-UHFFFAOYSA-N 0.000 claims 1
- ZJYNWOYILQHNNL-UHFFFAOYSA-N N-[2-(6,7-difluoro-2,4-dimethylindol-1-yl)ethyl]-6-[4-(2-methyl-1H-imidazol-5-yl)phenyl]pyrimidin-4-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1F)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C=1N=C(NC=1)C)C)C ZJYNWOYILQHNNL-UHFFFAOYSA-N 0.000 claims 1
- PJIITPYYFWWGFP-UHFFFAOYSA-N N-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-(1H-indol-5-yl)pyrimidin-4-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1F)CCNC1=NC=NC(=C1)C=1C=C2C=CNC2=CC=1)C)OC PJIITPYYFWWGFP-UHFFFAOYSA-N 0.000 claims 1
- UYRCMANWVCNRCY-UHFFFAOYSA-N N-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-[4-(1,2,4-oxadiazol-5-yl)phenyl]pyrimidin-4-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1F)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C1=NC=NO1)C)OC UYRCMANWVCNRCY-UHFFFAOYSA-N 0.000 claims 1
- GOCVYDWWRKLSAP-UHFFFAOYSA-N N-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-[4-(1H-imidazol-5-yl)phenyl]pyrimidin-4-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1F)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C=1N=CNC=1)C)OC GOCVYDWWRKLSAP-UHFFFAOYSA-N 0.000 claims 1
- IBABLQDXCZCAOU-UHFFFAOYSA-N N-[2-(6,7-difluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-[4-(2-methyl-1H-imidazol-5-yl)phenyl]pyrimidin-4-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1F)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C=1N=C(NC=1)C)C)OC IBABLQDXCZCAOU-UHFFFAOYSA-N 0.000 claims 1
- KFBFTEDXMWWBLC-UHFFFAOYSA-N N-[2-(6-fluoro-2,4-dimethylindol-1-yl)ethyl]-6-(1H-indol-5-yl)pyrimidin-4-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=NC=NC(=C1)C=1C=C2C=CNC2=CC=1)C)C KFBFTEDXMWWBLC-UHFFFAOYSA-N 0.000 claims 1
- CEDSEOSKLCAYLO-UHFFFAOYSA-N N-[2-(6-fluoro-2,4-dimethylindol-1-yl)ethyl]-6-[4-(2-methyl-1H-imidazol-5-yl)phenyl]pyrimidin-4-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C=1N=C(NC=1)C)C)C CEDSEOSKLCAYLO-UHFFFAOYSA-N 0.000 claims 1
- UJTOCBISEZQGEL-UHFFFAOYSA-N N-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-(1H-indol-5-yl)pyrimidin-4-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=NC=NC(=C1)C=1C=C2C=CNC2=CC=1)C)OC UJTOCBISEZQGEL-UHFFFAOYSA-N 0.000 claims 1
- QTCUPNKJJQMYGL-UHFFFAOYSA-N N-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-(4-pyrazin-2-ylphenyl)pyrimidin-4-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C1=NC=CN=C1)C)OC QTCUPNKJJQMYGL-UHFFFAOYSA-N 0.000 claims 1
- BVNPAMJFXWUROW-UHFFFAOYSA-N N-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-[4-(1-methylpyrazol-3-yl)phenyl]pyrimidin-4-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C1=NN(C=C1)C)C)OC BVNPAMJFXWUROW-UHFFFAOYSA-N 0.000 claims 1
- YUPHPBLOGLVKKO-UHFFFAOYSA-N N-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-[4-(2-methyl-1H-imidazol-5-yl)phenyl]pyrimidin-4-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C=1N=C(NC=1)C)C)OC YUPHPBLOGLVKKO-UHFFFAOYSA-N 0.000 claims 1
- BYJZRFSJNLHSGQ-UHFFFAOYSA-N N-[2-(6-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-[4-(5-methyl-1H-pyrazol-3-yl)phenyl]pyrimidin-4-amine Chemical compound FC1=CC(=C2C=C(N(C2=C1)CCNC1=NC=NC(=C1)C1=CC=C(C=C1)C1=NNC(=C1)C)C)OC BYJZRFSJNLHSGQ-UHFFFAOYSA-N 0.000 claims 1
- JEEJQZFJCKLFQD-UHFFFAOYSA-N N-[2-(7-chloro-4-methoxy-2-methylindol-1-yl)ethyl]-6-[3-(ethylamino)-4-(2H-tetrazol-5-yl)phenyl]pyrimidin-4-amine Chemical compound CCNC1=C(C=CC(=C1)C1=NC=NC(NCCN2C(C)=CC3=C(OC)C=CC(Cl)=C23)=C1)C1=NN=NN1 JEEJQZFJCKLFQD-UHFFFAOYSA-N 0.000 claims 1
- YINTXSFHWXUFRQ-UHFFFAOYSA-N N-[2-(7-fluoro-2,4-dimethylindol-1-yl)ethyl]-6-(1H-indol-5-yl)pyrimidin-4-amine Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1C=C2C=CNC2=CC=1)C)C YINTXSFHWXUFRQ-UHFFFAOYSA-N 0.000 claims 1
- NKVLAKQRBQZKJL-UHFFFAOYSA-N N-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-(1H-indol-5-yl)pyrimidin-4-amine Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1C=C2C=CNC2=CC=1)C)OC NKVLAKQRBQZKJL-UHFFFAOYSA-N 0.000 claims 1
- WXKINWLCARJNSX-UHFFFAOYSA-N N-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-[5-(2H-tetrazol-5-yl)-4-(trifluoromethyl)thiophen-2-yl]pyrimidin-4-amine Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1SC(=C(C=1)C(F)(F)F)C=1N=NNN=1)C)OC WXKINWLCARJNSX-UHFFFAOYSA-N 0.000 claims 1
- KAHZBFFYUGGPIW-UHFFFAOYSA-N N-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-[5-(2H-tetrazol-5-yl)thiophen-2-yl]pyrimidin-4-amine Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1SC(=CC=1)C1=NN=NN1)C)OC KAHZBFFYUGGPIW-UHFFFAOYSA-N 0.000 claims 1
- SARJDGXCJNUNIP-UHFFFAOYSA-N N-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethyl]-6-quinolin-6-ylpyrimidin-4-amine Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=NC=NC(=C1)C=1C=C2C=CC=NC2=CC=1)C)OC SARJDGXCJNUNIP-UHFFFAOYSA-N 0.000 claims 1
- QXIIVIKCFJXVST-UHFFFAOYSA-N N-[3-ethoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]-3-hydroxypropanamide Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)NC(CCO)=O QXIIVIKCFJXVST-UHFFFAOYSA-N 0.000 claims 1
- VAHXIKZLACZDLP-UHFFFAOYSA-N N-[3-ethoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]formamide Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)NC=O VAHXIKZLACZDLP-UHFFFAOYSA-N 0.000 claims 1
- SIZMRPNWTYBQPV-UHFFFAOYSA-N N-[3-ethoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]propanamide Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)NC(CC)=O SIZMRPNWTYBQPV-UHFFFAOYSA-N 0.000 claims 1
- DPJKFQKYXSMBIH-UHFFFAOYSA-N N-[4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]formamide Chemical compound C(#N)C=1N(C2=C(C=CC(=C2C=1)OC)F)CCNC1=CC(=NC=N1)C1=CC=C(C=C1)NC=O DPJKFQKYXSMBIH-UHFFFAOYSA-N 0.000 claims 1
- JTCXVYOJYVAFPK-UHFFFAOYSA-N N-ethyl-N-[5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophen-3-yl]formamide Chemical compound C(C)N(C=O)C1=CSC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C JTCXVYOJYVAFPK-UHFFFAOYSA-N 0.000 claims 1
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- KVFLIAYPPZPDLH-UHFFFAOYSA-N [2-(dimethylamino)-2-oxoethyl] 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylate Chemical compound CN(C(=O)COC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N)C KVFLIAYPPZPDLH-UHFFFAOYSA-N 0.000 claims 1
- MQISUGZXFKYYSR-UHFFFAOYSA-N [2-chloro-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]methanol Chemical compound ClC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)CO MQISUGZXFKYYSR-UHFFFAOYSA-N 0.000 claims 1
- IEFVBSJUSPMUBD-UHFFFAOYSA-N [2-ethoxy-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]phenyl]methanol Chemical compound C(C)OC1=C(C=CC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)CO IEFVBSJUSPMUBD-UHFFFAOYSA-N 0.000 claims 1
- YVKKQEPGRVRFIF-UHFFFAOYSA-N [3-ethoxy-5-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]thiophen-2-yl]urea Chemical compound C(C)OC1=C(SC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)NC(=O)N YVKKQEPGRVRFIF-UHFFFAOYSA-N 0.000 claims 1
- AGJDTSSPPOLBTM-UHFFFAOYSA-N [4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]-2-methoxyphenyl]methanol Chemical compound FC=1C=CC(=C2C=C(N(C=12)CCNC1=CC(=NC=N1)C1=CC(=C(C=C1)CO)OC)C)OC AGJDTSSPPOLBTM-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000012752 auxiliary agent Substances 0.000 claims 1
- 150000001556 benzimidazoles Chemical class 0.000 claims 1
- PBZBHEBREGAYFB-UHFFFAOYSA-N butanoyloxymethyl 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylate Chemical compound C(CCC)(=O)OCOC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N PBZBHEBREGAYFB-UHFFFAOYSA-N 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- WWKJVEWGUZMARL-UHFFFAOYSA-N ethoxycarbonyloxymethyl 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylate Chemical compound C(C)OC(=O)OCOC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N WWKJVEWGUZMARL-UHFFFAOYSA-N 0.000 claims 1
- KMYHETNDFKOZKQ-UHFFFAOYSA-N ethyl 2-[4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-methoxyphenyl]propanoate Chemical compound CCOC(=O)C(C)C1=C(C=C(C=C1)C2=CC(=NC=N2)NCCN3C(=CC4=C(C=CC(=C43)F)OC)C#N)OC KMYHETNDFKOZKQ-UHFFFAOYSA-N 0.000 claims 1
- PRBFVXUNUDCDTR-UHFFFAOYSA-N ethyl 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]thiophene-3-carboxylate Chemical compound C(C)OC(=O)C1=CSC(=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N PRBFVXUNUDCDTR-UHFFFAOYSA-N 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 claims 1
- 125000001786 isothiazolyl group Chemical group 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- XOHMDQPMMBYDAB-UHFFFAOYSA-N methyl 2-[2-ethoxy-4-[6-[2-(7-fluoro-4-methoxy-2-methylindol-1-yl)ethylamino]pyrimidin-4-yl]anilino]acetate Chemical compound COC(CNC1=C(C=C(C=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C)OCC)=O XOHMDQPMMBYDAB-UHFFFAOYSA-N 0.000 claims 1
- VTQFDDSUXWQVSY-UHFFFAOYSA-N methyl 2-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-1H-indole-5-carboxylate Chemical compound COC(=O)C=1C=C2C=C(NC2=CC=1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N VTQFDDSUXWQVSY-UHFFFAOYSA-N 0.000 claims 1
- PVKNTWHNCDCTIX-UHFFFAOYSA-N methyl 4-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-2-fluorobenzoate Chemical compound COC(C1=C(C=C(C=C1)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N)F)=O PVKNTWHNCDCTIX-UHFFFAOYSA-N 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- JYGORZJPZSPYLF-UHFFFAOYSA-N phenyl 5-[6-[2-(2-cyano-7-fluoro-4-methoxyindol-1-yl)ethylamino]pyrimidin-4-yl]-3-ethoxythiophene-2-carboxylate Chemical compound C1(=CC=CC=C1)OC(=O)C=1SC(=CC=1OCC)C1=NC=NC(=C1)NCCN1C(=CC2=C(C=CC(=C12)F)OC)C#N JYGORZJPZSPYLF-UHFFFAOYSA-N 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000002098 pyridazinyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000004550 quinolin-6-yl group Chemical group N1=CC=CC2=CC(=CC=C12)* 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (20)
1. Spoj, naznačen time, da je predstavljen, formulom (I)
[image]
u kojoj
(R1)n predstavlja jedan, dva ili tri opcionalna supstituenta na indolskom prstenu, gdje se spomenuti supstituenti neovisno biraju od sljedećih: (C13)alkil, (C13)alkoksi, halogen, (C13)fluoroalkil, (C13)fluoroalkoksi, ili cijano; ili dva R1 zajedno tvore skupinu –O-CH2-O-, i preostali R1, ako postoji, predstavlja halogen;
R2 predstavlja (C14)alkil, halogen ili cijano;
R3 predstavlja vodik, metil ili trifluorometil;
R4a i R4b neovisno predstavljaju vodik, metil, ili R4a i R4b zajedno s ugljikovim atomom s kojim su oni vezani, predstavljaju cikloprop-1,1-diil skupinu;
R5a i R5b neovisno predstavljaju vodik, metil, ili R5a i R5b zajedno s ugljikovim atomom s kojim su oni vezani, predstavljaju cikloprop-1,1-diil skupinu;
Ar1 predstavlja
• fenil, ili 5-člani ili 6-člani heteroaril; gdje je spomenuti fenil ili 5-člani ili 6-člani heteroaril neovisno monosupstituiran, disupstituiran ili trisupstituiran, pri čemu se supstituenti neovisno biraju od sljedećih:
• (C1-6)alkil;
• (C1-4)alkoksi;
• (C1-3)fluoroalkil, gdje je spomenuti (C1-3)fluoroalkil opcionalno supstituiran s hidroksi;
• (C1-3)fluoroalkoksi;
• halogen;
• cijano;
• (C3-6)cikloalkil, gdje je spomenuti (C3-6)cikloalkil nesupstituiran ili monosupstituiran s amino;
• (C4-6)cikloalkil koji sadrži prstenov atom kisika, gdje je spomenuti (C4-6)cikloalkil koji sadrži prstenov atom kisika nesupstituiran ili monosupstituiran s fluoro, hidroksi ili metoksi;
• (C3-6)cikloalkil-oksi;
• hidroksi;
• nitro;
• -B(OH)2;
• 2,2,2-trifluoro-1,1-dihidroksi-etil;
• -X1-CO-RO1, gdje
▪ X1 predstavlja izravnu vezu, (C1-3)alkilen, -O-(C1-3)alkilen-*, -NH-(C1-3)alkilen-*, -S-CH2-*, -CF2-, –CH=CH-, –C≡C-, -NH-CO-*, -CO-, ili (C3-5)cikloalkilen; gdje zvjezdice označavaju vezu koja je spojena sa -CO-RO1 skupinom; i
▪ RO1 predstavlja
• -OH;
• -O-(C1-4)alkil;
• -NH-SO2-RS3 gdje RS3 predstavlja (C1-4)alkil, (C3-6)cikloalkil pri čemu (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C3-6)cikloalkil-(C1-3)alkilen dok (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C1-3)fluoroalkil, fenil ili -NH2;
• -O-fenil;
• -O-CH2-CO-RO4, gdje RO4 predstavlja hidroksi, ili (C1-4)alkoksi, ili -N[(C1-4)alkil]2;
• -O-CH2-O-CO-RO5, gdje RO5 predstavlja (C1-4)alkil ili (C1-4)alkoksi;
• -O-CH2-CH2-N[(C1-4)alkil]2; ili
• (5-metil-2-okso-[1,3]dioksol-4-il)-metiloksi-;
• -CO-CH2-CN;
• -CO-CH2-OH;
• -CO-H;
•
[image]
;
•
[image]
;
• 2-hidroksi-3,4-diokso-ciklobut-1-enil;
• hidroksi-(C1-4)alkil;
• dihidroksi-(C2-4)alkil;
• hidroksi-(C2-4)alkoksi;
• (C1-4)alkoksi-(C2-4)alkoksi;
• -(CH2)m-NRN1RN2, gdje m predstavlja cijeli broj 0 ili 1; i gdje
• RN1 i RN2 neovisno predstavljaju vodik, (C1-4)alkil, (C1-4)alkoksi-(C2-4)alkil, (C3-6)cikloalkil, (C2-3)fluoroalkil, -ili -SO2-(C1-4)alkil;
• ili RN1 neovisno predstavlja vodik ili (C1-4)alkil, i RN2 neovisno predstavlja –CO-H, –CO-(C1-3)alkil, –CO-(C1-3)alkilen-OH, ili –CO-O-(C1-3)alkil;
• ili RN1 i RN2 zajedno s dušikom s kojim su oni vezani, tvore 4-člani, 5-člani ili 6-člani zasićeni prsten koji opcionalno sadrži jedan prstenov atom kisika ili prstenov atom sumpora, pri čemu je spomenuti prsten nesupstituiran, ili monosupstituiran s okso na prstenovom atomu ugljika, ili disupstituiran s okso na prstenovom atomu sumpora;
• -CO-NRN3RN4 gdje RN3 i RN4 neovisno predstavljaju vodik, (C1-4)alkil, hidroksi-(C2-4)alkil, (C1-3)alkoksi-(C2-4)alkil, dimetilamino-(C2-4)alkil, (C1-4)alkoksi, hidroksi-(C2-4)alkoksi, benziloksi, ili hidroksi;
• -NH-CO-NRN5RN6 gdje RN5 i RN6 neovisno predstavljaju vodik ili (C1-4)alkil;
• -SO2-RS1 gdje RS1 predstavlja hidroksi, (C1-4)alkil, ili -NRN7RN8 gdje RN7 i RN8 neovisno predstavljaju vodik ili (C1-3)alkil;
• -S-RS2 gdje RS2 predstavlja (C1-4)alkil, (C3-6)cikloalkil, ili 2-fluoro-vinil;
• 5-okso-4,5-dihidro-[1,2,4]oksadiazol-3-il, ili 3-okso-2,3-dihidro-[1,2,4]oksadiazol-5-il;
• fenil-oksi, gdje je fenil opcionalno monosupstituiran s halogenom;
• benzooksazol-2-il; ili
• -(CH2)p-HET, gdje p predstavlja cijeli broj 0 ili 1; i gdje HET predstavlja 5-člani ili 6-člani heteroaril, pri čemu je spomenuti 5-člani ili 6-člani heteroaril nesupstituiran, ili monosupstituiran ili disupstituiran, gdje se supstituenti neovisno biraju od sljedećih: (C1-4)alkil, (C1-4)alkoksi, -COOH, hidroksi, fluoro, 2-amino-2-okso-etil, 2-karboksi-etil, (C3-5)cikloalkil, ili -NRN9RN10 dok RN9 i RN10 neovisno predstavljaju vodik ili (C1-3)alkil;
• ili Ar1 predstavlja 8-člani do 10-člani biciklički heteroaril; gdje je spomenuti 8-člani do 10-člani biciklički heteroaril neovisno nesupstituiran, monosupstituiran, disupstituiran ili trisupstituiran, pri čemu se supstituenti neovisno biraju od sljedećih: (C1-4)alkil; (C1-4)alkoksi; (C1-3)fluoroalkil; (C1-3)fluoroalkoksi; halogen; cijano; hidroksi, ili -(C0-3)alkilen-COORO2 gdje RO2 predstavlja vodik ili (C1-4)alkil;
• ili Ar1 predstavlja 8-člani do 10-člani djelomično aromatski staljeni biciklički heterociklil koji sadrži jedan do četiri heteroatoma neovisno odabrana od dušika, kisika i sumpora; gdje je spomenuti 8-člani do 10-člani heterociklil vezan s preostalim dijelom molekule na aromatskom prstenovom ostatku; pri čemu je spomenuti 8-člani do 10-člani heterociklil neovisno nesupstituiran, monosupstituiran ili disupstituiran, gdje se supstituenti neovisno biraju od sljedećih: okso, (C1-6)alkil, i -(C0-3)alkilen-COORO3 dok RO3 predstavlja vodik ili (C1-3)alkil;
ili njegova farmaceutski prihvatljiva sol.
2. Spoj prema patentnom zahtjevu 1; naznačen time, da R3 predstavlja vodik;
ili njegova farmaceutski prihvatljiva sol.
3. Spoj prema patentnim zahtjevima 1 ili 2; naznačen time, da
• R4a i R4b oba predstavljaju vodik; i
• R5a i R5b oba predstavljaju vodik;
ili njegova farmaceutski prihvatljiva sol.
4. Spoj prema bilo kojem od patentnih zahtjeva 1 do 3; naznačen time, da Ar1 predstavlja
• fenil, ili 5-člani ili 6-člani heteroaril; gdje je spomenuti fenil ili 5-člani9 ili 6-člani heteroaril neovisno monosupstituiran, disupstituiran ili trisupstituiran;
pri čemu se jedan od navedenih supstituenata bira od sljedećih:
• (C1-4)alkoksi;
• (C1-3)fluoroalkil, gdje je spomenuti (C1-3)fluoroalkil nesupstituiran ili monosupstituiran s hidroksi;
• (C3-6)cikloalkil, gdje je spomenuti (C3-6)cikloalkil nesupstituiran ili monosupstituiran s amino;
• (C4-6)cikloalkil koji sadrži prstenov atom kisika, pri čemu je spomenuti (C4-6)cikloalkil koji sadrži prstenov atom kisika nesupstituiran ili monosupstituiran s fluoro, hidroksi ili metoksi;
• hidroksi;
• -B(OH)2;
• 2,2,2-trifluoro-1,1-dihidroksi-etil;
• -X1-CO-RO1, gdje
▪ X1 predstavlja izravnu vezu, (C1-3)alkilen, -O-(C1-3)alkilen-*, -NH-(C1-3)alkilen-*, -S-CH2-*, -CF2-, –CH=CH-, –C≡C-, -NH-CO-*, -CO-, ili (C3-5)cikloalkilen; gdje zvjezdice označavaju vezu koja je spojena sa -CO-RO1 skupinom; i
▪ RO1 predstavlja
• -OH;
• -O-(C1-4)alkil;
• -NH-SO2-RS3 gdje RS3 predstavlja (C1-4)alkil, (C3-6)cikloalkil pri čemu (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C3-6)cikloalkil-(C1-3)alkilen gdje (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C1-3)fluoroalkil, fenil, ili -NH2;
• -O-fenil;
• -O-CH2-CO-RO4, gdje RO4 predstavlja hidroksi, ili (C1-4)alkoksi, ili -N[(C1-4)alkil]2;
• -O-CH2-O-CO-RO5, gdje RO5 predstavlja (C1-4)alkil ili (C1-4)alkoksi;
• -O-CH2-CH2-N[(C1-4)alkil]2; ili
• (5-metil-2-okso-[1,3]dioksol-4-il)-metiloksi-;
• -CO-CH2-CN;
• -CO-CH2-OH;
• -CO-H;
•
[image]
;
•
[image]
;
• 2-hidroksi-3,4-diokso-ciklobut-1-enil;
• hidroksi-(C1-4)alkil;
• dihidroksi-(C2-4)alkil;
• hidroksi-(C2-4)alkoksi;
• (C1-4)alkoksi-(C2-4)alkoksi;
• -(CH2)m-NRN1RN2, gdje m predstavlja cijeli broj 0 ili 1; i pri čemu
▪ RN1 i RN2 neovisno predstavljaju vodik, (C1-4)alkil, (C1-4)alkoksi-(C2-4)alkil, (C3-6)cikloalkil, (C2-3)fluoroalkil, ili -SO2-(C1-4)alkil;
▪ ili RN1 neovisno predstavlja vodik ili (C1-4)alkil, i RN2 neovisno predstavlja –CO-H, –CO-(C1-3)alkil, –CO-(C1-3)alkilen-OH, ili –CO-O-(C1-3)alkil;
▪ ili RN1 i RN2 zajedno s dušikom s kojim su oni vezani, tvore 4-člani, 5-člani ili 6-člani zasićeni prsten koji opcionalno sadrži jedan prstenov atom kisika ili prstenov atom sumpora, gdje je spomenuti prsten nesupstituiran, ili monosupstituiran s okso na prstenovom atomu ugljika, ili disupstituiran s okso na prstenovom atomu sumpora;
• -CO-NRN3RN4 gdje RN3 i RN4 neovisno predstavljaju vodik, (C1-4)alkil, hidroksi-(C2-4)alkil, (C1-3)alkoksi-(C2-4)alkil, dimetilamino-(C2-4)alkil, (C1-4)alkoksi, hidroksi-(C2-4)alkoksi, benziloksi, ili hidroksi;
• -NH-CO-NRN5RN6 gdje RN5 i RN6 neovisno predstavljaju vodik ili (C1-4)alkil;
• -SO2-RS1 gdje RS1 predstavlja hidroksi, (C1-4)alkil, ili -NRN7RN8 dok RN7 i RN8 neovisno predstavljaju vodik ili (C1-3)alkil;
• 5-okso-4,5-dihidro-[1,2,4]oksadiazol-3-il ili 3-okso-2,3-dihidro-[1,2,4]oksadiazol-5-il;
• benzooksazol-2-il; ili
• -(CH2)p-HET, gdje p predstavlja cijeli broj 0 ili 1; i gdje HET predstavlja 5-člani ili 6-člani heteroaril, pri čemu je spomenuti 5-člani ili 6-člani heteroaril nesupstituiran, ili monosupstituiran ili disupstituiran, gdje se supstituenti neovisno biraju od sljedećih: (C1-4)alkil, (C1-4)alkoksi, -COOH, hidroksi, fluoro, 2-amino-2-okso-etil, 2-karboksi-etil, (C3-5)cikloalkil, ili -NRN9RN10 dok RN9 i RN10 neovisno predstavljaju vodik ili (C1-3)alkil;
i preostali jedan ili dva od navedenih supstituenata, ako postoje, neovisno se biraju od sljedećih:
• (C1-6)alkil;
• (C1-4)alkoksi;
• (C1-3)fluoroalkil;
• (C1-3)fluoroalkoksi;
• halogen;
• (C3-6)cikloalkil;
• (C3-6)cikloalkil-oksi;
• hidroksi;
• nitro;
• -(CH2)m-NRN1RN2, gdje m predstavlja cijeli broj 0 ili 1; i gdje RN1 i RN2 neovisno predstavljaju vodik, (C1-4)alkil, (C1-4)alkoksi-(C2-4)alkil, (C3-6)cikloalkil, (C2-3)fluoroalkil, -ili -SO2-(C1-4)alkil; ili RN1 i RN2 zajedno s dušikom s kojim su oni vezani, tvore 5-člani ili 6-člani zasićeni prsten koji opcionalno sadrži jedan prstenov atom kisika ili prstenov atom sumpora, pri čemu je spomenuti prsten nesupstituiran, ili monosupstituiran s okso na prstenovom atomu ugljika, ili disupstituiran s okso na prstenovom atomu sumpora;
• -S-RS2 gdje RS2 predstavlja (C1-4)alkil, (C3-6)cikloalkil, ili 2-fluoro-vinil; ili
• fenil-oksi, gdje je fenil opcionalno monosupstituiran s halogenom;
• ili Ar1 predstavlja 8-člani do 10-člani biciklički heteroaril; gdje je spomenuti 8-člani do 10-člani biciklički heteroaril neovisno nesupstituiran, monosupstituiran, disupstituiran ili trisupstituiran, pri čemu se supstituenti neovisno biraju od sljedećih: (C1-4)alkil; (C1-4)alkoksi; (C1-3)fluoroalkil; halogen; i -(C0-3)alkilen-COORO2 gdje RO2 predstavlja vodik ili (C1-4)alkil;
• ili Ar1 predstavlja 8-člani do 10-člani djelomično aromatski staljeni biciklički heterociklil koji sadrži jedan do četiri heteroatoma neovisno odabrana od dušika, kisika i sumpora; gdje je spomenuti 8-člani do 10-člani heterociklil vezan s preostalim dijelom molekule na aromatskom prstenovom ostatku; pri čemu je spomenuti 8-člani do 10-člani heterociklil neovisno nesupstituiran, monosupstituiran ili disupstituiran, dok se supstituenti neovisno biraju od sljedećih: okso, (C1-6)alkil, i -(C0-3)alkilen-COORO3 gdje RO3 predstavlja vodik ili (C1-3)alkil;
ili njegova farmaceutski prihvatljiva sol.
5. Spoj prema bilo kojem od patentnih zahtjeva 1 do 3; naznačen time, da Ar1 predstavlja
• fenil skupinu sa strukturom (Ar-IV):
[image]
u kojoj
• Rp predstavlja:
→ (C4-6)cikloalkil koji sadrži prstenov atom kisika, gdje je spomenuti (C4-6)cikloalkil koji sadrži prstenov atom kisika nesupstituiran, ili monosupstituiran s fluoro, hidroksi ili metoksi;
→ hidroksi;
→ -X1-CO-RO1, gdje
→ X1 predstavlja izravnu vezu, (C1-3)alkilen, -O-(C1-3)alkilen-*, -NH-(C1-3)alkilen-*, -S-CH2-*, -CF2-, –CH=CH-, –C≡C-, -NH-CO-*, -CO-, ili (C3-5)cikloalkilen; gdje zvjezdice označavaju vezu koja je spojena sa -CO-RO1 skupinom; i
→ RO1 predstavlja
▪ -OH;
▪ -O-(C1-4)alkil;
▪ -NH-SO2-RS3 gdje RS3 predstavlja (C1-4)alkil, (C3-6)cikloalkil gdje (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C3-6)cikloalkil-(C1-3)alkilen gdje (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C1-3)fluoroalkil, fenil, ili -NH2;
▪ -O-CH2-CO-RO4, gdje RO4 predstavlja hidroksi, ili (C1-4)alkoksi, ili -N[(C1-4)alkil]2;
▪ -O-CH2-O-CO-RO5, gdje RO5 predstavlja (C1-4)alkil ili (C1-4)alkoksi;
▪ -O-CH2-CH2-N[(C1-4)alkil]2; ili
▪ (5-metil-2-okso-[1,3]dioksol-4-il)-metiloksi-;
→ -CO-H;
→
[image]
;
→ 2-hidroksi-3,4-diokso-ciklobut-1-enil;
→ -NRN1RN2, gdje
▪ RN1 neovisno predstavlja vodik ili (C1-4)alkil, i RN2 neovisno predstavlja –CO-H, –CO-(C1-3)alkil, ili –CO-(C1-3)alkilen-OH;
→ -CO-NRN3RN4 gdje RN3 i RN4 neovisno predstavljaju vodik, (C1-4)alkil, hidroksi-(C2-4)alkil, (C1-3)alkoksi-(C2-4)alkil, ili hidroksi;
→ -NH-CO-NRN5RN6 gdje RN5 i RN6 neovisno predstavljaju vodik ili (C1-4)alkil;
→ 5-okso-4,5-dihidro-[1,2,4]oksadiazol-3-il ili 3-okso-2,3-dihidro-[1,2,4]oksadiazol-5-il;
→ HET, gdje HET predstavlja 5-člani ili 6-člani heteroaril, pri čemu je spomenuti 5-člani ili 6-člani heteroaril nesupstituiran, ili monosupstituiran ili disupstituiran, dok se supstituenti neovisno biraju od sljedećih:
(C1-4)alkil, (C1-4)alkoksi, -COOH, hidroksi, fluoro, 2-amino-2-okso-etil, 2-karboksi-etil, (C3-5)cikloalkil, ili -NRN9RN10 gdje RN9 i RN10 neovisno predstavljaju vodik ili (C1-3)alkil;
• Rm1 predstavlja
→ (C1-6)alkil;
→ (C1-4)alkoksi;
→ (C1-3)fluoroalkil;
→ (C1-3)fluoroalkoksi;
→ halogen;
→ (C3-6)cikloalkil;
→ (C3-6)cikloalkil-oksi;
→ -NRN1RN2, gdje RN1 i RN2 neovisno predstavljaju vodik, (C1-4)alkil, ili (C3-6)cikloalkil; ili
→ -S-RS2 gdje RS2 predstavlja (C1-4)alkil, (C3-6)cikloalkil, ili 2-fluoro-vinil; i
• Rm2 predstavlja vodik, fluoro ili kloro;
• ili Rp predstavlja vodik;
Rm1 predstavlja 1H-pirazol-1-il; ili -X1-COOH, gdje X1 predstavlja izravnu vezu, (C1-3)alkilen, ili -O-(C1-3)alkilen-*, gdje zvjezdice označavaju vezu koja je spojena sa -COOH skupinom;
i Rm2predstavlja vodik, (C1-4)alkoksi; ili -S-(C1-4)alkil;
• ili Ar1 predstavlja 5-članu heteroarilnu skupinu sa strukturom (Ar-II):
[image]
pri čemu u (Ar-II) prsten A predstavlja tiofenil ili tiazolil prsten;
gdje
• R7 predstavlja
→ 3-hidroksi-oksetan-3-il;
→ hidroksi;
→ 2,2,2-trifluoro-1,1-dihidroksi-etil;
→ -X1-CO-RO1, gdje
→ X1 predstavlja izravnu vezu, (C1-3)alkilen, -O-(C1-3)alkilen-*, -NH-(C1-3)alkilen-*, -S-CH2-*, -CF2-, –CH=CH-, –C≡C-, -NH-CO-*, -CO-, ili (C3-5)cikloalkilen; gdje zvjezdice označavaju vezu koja je spojena sa -CO-RO1 skupinom; i
→ RO1 predstavlja
▪ -OH;
▪ -O-(C1-4)alkil;
▪ -NH-SO2-RS3 gdje RS3 predstavlja (C1-4)alkil, (C3-6)cikloalkil gdje (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C3-6)cikloalkil-(C1-3)alkilen pri čemu (C3-6)cikloalkil opcionalno sadrži prstenov atom kisika, (C1-3)fluoroalkil, fenil, ili -NH2;
▪ -O-fenil;
▪ -O-CH2-CO-RO4, gdje RO4 predstavlja hidroksi, ili (C1-4)alkoksi, ili -N[(C1-4)alkil]2;
▪ -O-CH2-O-CO-RO5, gdje RO5 predstavlja (C1-4)alkil ili (C1-4)alkoksi;
▪ -O-CH2-CH2-N[(C1-4)alkil]2; ili
▪ (5-metil-2-okso-[1,3]dioksol-4-il)-metiloksi-;
→ -CO-CH2-OH;
→ -CO-H;
→
[image]
;
→ hidroksi-(C1-4)alkil;
→ -NRN1RN2, gdje
▪ RN1 i RN2 neovisno predstavljaju vodik, (C1-4)alkil, ili (C3-6)cikloalkil;
▪ ili RN1 neovisno predstavlja vodik ili (C1-4)alkil, i RN2 neovisno predstavlja –CO-H, –CO-(C1-3)alkil, ili –CO-(C1-3)alkilen-OH;
→ -CO-NRN3RN4 gdje RN3 i RN4 neovisno predstavljaju vodik, (C1-4)alkil, hidroksi-(C2-4)alkil, (C1-3)alkoksi-(C2-4)alkil, dimetilamino-(C2-4)alkil, (C1-4)alkoksi, hidroksi-(C2-4)alkoksi, benziloksi, ili hidroksi;
→ -NH-CO-NRN5RN6 gdje RN5 i RN6 neovisno predstavljaju vodik ili (C1-4)alkil;
→ 5-okso-4,5-dihidro-[1,2,4]oksadiazol-3-il ili 3-okso-2,3-dihidro-[1,2,4]oksadiazol-5-il; ili
→ HET, gdje HET predstavlja 5-člani ili 6-člani heteroaril, pri čemu je spomenuti 5-člani ili 6-člani heteroaril nesupstituiran, ili monosupstituiran ili disupstituiran, dok se supstituenti neovisno biraju od sljedećih:
(C1-4)alkil, (C1-4)alkoksi, -COOH, hidroksi, fluoro, 2-amino-2-okso-etil, 2-karboksi-etil, (C3-5)cikloalkil, ili -NRN9RN10 gdje RN9 i RN10 neovisno predstavljaju vodik ili (C1-3)alkil;
• i (R6)n predstavlja jedan opcionalni supstituent koji se neovisno bira od sljedećih:
→ (C1-6)alkil;
→ (C1-4)alkoksi;
→ (C1-3)fluoroalkil;
→ (C1-3)fluoroalkoksi;
→ halogen;
→ (C3-6)cikloalkil;
→ (C3-6)cikloalkil-oksi;
→ hidroksi;
→ piridinil; i
→ -NRN1RN2, gdje RN1 i RN2 neovisno predstavljaju vodik, (C1-4)alkil, ili (C3-6)cikloalkil;
• ili Ar1 predstavlja 9-člani ili 10-člani biciklički heteroaril; gdje je spomenuti 9-člani ili 10-člani biciklički heteroaril neovisno nesupstituiran, monosupstituiran ili disupstituiran, pri čemu se supstituenti neovisno biraju od sljedećih:
(C1-4)alkil; (C1-4)alkoksi; (C1-3)fluoroalkil; (C1-3)fluoroalkoksi; halogen; cijano; hidroksi, ili -(C0-3)alkilen-COORO2 gdje RO2 predstavlja vodik ili (C1-4)alkil;
• ili Ar1 predstavlja skupinu sa strukturom (Ar-III):
[image]
u kojoj prsten (B) predstavlja nearomatski 5-člani ili 6-člani prsten staljen na fenilnu skupinu, gdje prsten (B) sadrži jedan ili dva heteroatoma neovisno odabrana od dušika i kisika; pri čemu je spomenuti prsten (B) neovisno nesupstituiran, monosupstituiran ili disupstituiran, dok se supstituenti neovisno biraju od sljedećih: okso,
(C1-6)alkil, i -(C0-3)alkilen-COORO3 gdje RO3 predstavlja vodik ili (C1-3)alkil;
ili njegova farmaceutski prihvatljiva sol.
6. Spoj prema bilo kojem od patentnih zahtjeva 1 do 3; naznačen time, da
• Ar1 predstavlja fenilnu skupinu koja se bira od:
a)
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
i
[image]
; ili
b)
[image]
i
[image]
; ili
c)
[image]
; ili
d)
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
i
[image]
;
• ili Ar1 predstavlja tiofenilnu skupinu koja se bira od:
a)
[image]
[image]
[image]
[image]
[image]
[image]
[image]
.. i
[image]
; ili
b)
[image]
[image]
[image]
i
[image]
; ili
c)
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
i
[image]
;
• ili Ar1 predstavlja tiazoil skupinu koja se bira od:
[image]
[image]
[image]
[image]
[image]
i
[image]
;
• ili Ar1 predstavlja 9-člani ili 10-člani biciklički heteroaril koji se bira od:
a)
[image]
; ili
b)
[image]
[image]
[image]
[image]
[image]
[image]
i
[image]
;
• ili Ar1 predstavlja skupinu koja se bira od:
a)
[image]
; ili
b)
[image]
[image]
[image]
[image]
[image]
i
[image]
;
ili njegova farmaceutski prihvatljiva sol.
7. Spoj prema bilo kojem od patentnih zahtjeva 1 do 6; naznačen time, da skupina
[image]
predstavlja
[image]
u kojoj
R2 predstavlja metil, kloro ili cijano; i
R13 predstavlja vodik; i
• R14, R15, R16, i R17 neovisno predstavljaju sljedeće:
R14 predstavlja vodik, metil, etil, metoksi, bromo, kloro, fluoro, trifluorometil, trifluorometoksi ili cijano;
R15 predstavlja vodik, metil, metoksi, kloro, fluoro;
R16 predstavlja vodik, metoksi ili fluoro; i
R17 predstavlja vodik, metil, metoksi, kloro, fluoro ili cijano;
pri čemu najmanje jedan od R14, R15, R16 i R17 predstavlja vodik;
• ili R14 i R15 zajedno tvore skupinu –O-CH2-O-, R16 predstavlja vodik i R17 predstavlja vodik ili halogen;
ili
R2 predstavlja (C13)alkil, halogen ili cijano; i
R13 predstavlja fluoro; i
• R14, R15, R16 i R17 neovisno predstavljaju sljedeće:
R14 predstavlja vodik, metil, etil, metoksi, bromo, kloro, fluoro, trifluorometil, trifluorometoksi ili cijano;
R15 predstavlja vodik, metil, metoksi, kloro, fluoro;
R16 predstavlja vodik, metoksi ili fluoro; i
R17 predstavlja vodik, metil, metoksi, kloro, fluoro ili cijano;
pri čemu najmanje dva od R14, R15, R16 i R17 predstavljaju vodik.
ili njegova farmaceutski prihvatljiva sol.
8. Spoj prema bilo kojem od patentnih zahtjeva 1 do 6; naznačen time, da skupina
[image]
predstavlja skupinu koja se bira od sljedećih skupina A), B), C), D) i E):
A)
[image]
[image]
[image]
i
[image]
;
B)
[image]
i
[image]
;
C)
[image]
[image]
i
[image]
;
D)
[image]
i
[image]
;
E)
[image]
[image]
i
[image]
;
ili njegova farmaceutski prihvatljiva sol.
9. Spoj prema patentnom zahtjevu 1; naznačen time, da je on spoj formule (II)
[image]
u kojoj
R2 predstavlja metil, kloro ili cijano; i
• R14, R15, R16 i R17 neovisno predstavljaju sljedeće:
R14 predstavlja metil, metoksi, halogen ili cijano;
R15 predstavlja vodik, metil, kloro ili fluoro;
R16 predstavlja vodik ili fluoro; i
R17 predstavlja vodik, kloro ili fluoro;
gdje najmanje jedan od R15, R16 i R17 predstavlja vodik
i Ar1 predstavlja
• fenilnu skupinu sa strukturom (Ar-IV):
[image]
u kojoj
• Rp predstavlja:
→ hidroksi;
→ -COOH;
→ -CO-CH2-CN;
→ -CO-(C1-4)alkoksi;
→ -CO-NH-SO2-RS3 gdje RS3 predstavlja RS3 predstavlja (C1-4)alkil, (C3-6)cikloalkil; (C3-6)cikloalkil-(C1-3)alkil; (C1-3)fluoroalkil, fenil, ili -NH2;
→ -X1-CH2-COOH, gdje X1 predstavlja O, ili NH;
→ -CO-NRN3RN4 gdje RN3 i RN4 neovisno predstavljaju vodik, (C1-4)alkil, hidroksi-(C2-4)alkil, (C1-3)alkoksi-(C2-4)alkil, dimetilamino-(C2-4)alkil, (C1-4)alkoksi, ili hidroksi-(C2-4)alkoksi;
→ -NH-CO-NRN5RN6 gdje RN5 i RN6 neovisno predstavljaju vodik ili (C1-4)alkil;
→ -SO2-RS1 gdje RS1 predstavlja hidroksi, (C1-4)alkil, ili -NRN7RN8 gdje RN7 i RN8 neovisno predstavljaju vodik ili (C1-3)alkil;
→ 5-okso-4,5-dihidro-[1,2,4]oksadiazol-3-il;
→ tetrazolil (posebice 1H-tetrazol-5-il); ili
→ 5-člani ili 6-člani heteroaril koji se bira od oksazolila, izoksazolila, oksadiazolila, tiazolila, izotiazolila, tiadiazolila, imidazolila, pirazolila, triazolila, piridinila, pirimidinila, piridazinila, ili pirazinila; gdje je spomenuti 5-člani ili 6-člani heteroaril nesupstituiran, ili monosupstituiran ili disupstituiran, pri čemu se supstituenti neovisno biraju od sljedećih: (C1-3)alkil, (C1-3)alkoksi, -COOH, hidroksi, fluoro, 2-amino-2-okso-etil, 2-karboksi-etil, ili -NRN9RN10 gdje RN9 i RN10 neovisno predstavljaju vodik ili (C1-3)alkil;
• Rm1 predstavlja
→ vodik;
→ (C1-6)alkil;
→ (C1-4)alkoksi;
→ (C1-3)fluoroalkil;
→ (C1-3)fluoroalkoksi;
→ halogen;
→ (C3-6)cikloalkil;
→ (C3-6)cikloalkil-oksi;
→ hidroksi;
→ -(CH2)m-NRN1RN2, gdje m predstavlja cijeli broj 0 ili 1; i gdje RN1 i RN2 neovisno predstavljaju vodik, (C1-3)alkil, ili (C2-3)fluoroalkil; ili RN1 i RN2 zajedno s dušikom s kojim su oni vezani, tvore pirolidinil prsten; ili
→ -S-RS2 gdje RS2 predstavlja (C1-4)alkil, ili (C3-6)cikloalkil;
• i Rm2 predstavlja
→ vodik; ili
→ (C1-6)alkil;
→ (C1-3)alkoksi; ili
→ halogen;
• ili Ar1 predstavlja 5-članu heteroarilnu skupinu sa strukturom (Ar-V):
[image]
gdje u (Ar-V) prsten A predstavlja tiofenil ili tiazolil prsten;
gdje RA1 predstavlja
→ -COOH;
→ tetrazolil;
→ -CO-(C1-4)alkoksi;
→ -CO-NH-SO2-RS3 gdje RS3 predstavlja (C1-4)alkil, (C3-6)cikloalkil; (C3-6)cikloalkil-(C1-3)alkil; (C1-3)fluoroalkil, fenil, ili -NH2;
→ -X1-CH2-COOH, gdje X1 predstavlja O, ili NH; ili
→ -CO-NRN3RN4 gdje RN3 i RN4 neovisno predstavljaju vodik, (C1-4)alkil, hidroksi-(C2-4)alkil, ili (C1-3)alkoksi-(C2-4)alkil;
i RA2 predstavlja
→ vodik;
→ (C1-6)alkil;
→ (C1-4)alkoksi;
→ (C1-3)fluoroalkil;
→ halogen; ili
→ hidroksi;
• ili Ar1 predstavlja 9-člani ili 10-člani biciklički heteroaril koji se bira od sljedećih: 1H-indol-5-il, 1H-indol-4-il, 1H-indol-6-il, indazol-6-il, 1H-benzoimidazol-5-il, 1H-benzotriazol-5-il, kinoksalin-6-il, izokinolin-7-il, i kinolin-6-il; gdje je spomenuti 9-člani ili 10-člani biciklički heteroaril neovisno nesupstituiran, monosupstituiran ili disupstituiran, pri čemu se supstituenti neovisno biraju od (C1-4)alkila ili –COOH;
• ili Ar1 predstavlja skupinu sa strukturom (Ar-III):
[image]
u kojoj prsten (B) predstavlja nearomatski 5-člani prsten staljen na fenilnu skupinu, gdje prsten (B) sadrži jedan ili dva prstenova atoma dušika; pri čemu je spomenuti prsten (B) neovisno nesupstituiran, monosupstituiran ili disupstituiran, dok se supstituenti neovisno biraju od okso i (C1-6)alkila;
ili njegova farmaceutski prihvatljiva sol.
10. Spoj prema patentnom zahtjevu 1, naznačen time, da je on spoj formule (III):
[image]
u kojoj skupina:
[image]
predstavlja skupinu koja se bira od sljedećih skupina A), B), C), D) i E):
A)
[image]
[image]
i
[image]
;
B)
[image]
[image]
i
[image]
;
C)
[image]
i
[image]
;
D)
[image]
;
E)
[image]
[image]
i
[image]
; i
Ar1 predstavlja
• fenil, ili 5-člani heteroaril koji je odabran od tiofenila i tiazolila; gdje je spomenuti fenil ili 5-člani heteroaril neovisno monosupstituiran, disupstituiran ili trisupstituiran;
pri čemu se jedan od navedenih supstituenata bira od sljedećih:
• -X1-CO-RO1, gdje
▪ X1 predstavlja izravnu vezu, -CH2-CH2-, -O-CH2-*, -NH-CH2-*, –CH=CH-, ili -NH-CO-*; gdje zvjezdice označavaju vezu koja je spojena sa -CO-RO1 skupinom; i
▪ RO1 predstavlja
• -OH;
• -O-(C1-4)alkil;
• -NH-SO2-RS3 gdje RS3 predstavlja (C1-3)alkil, ciklopropil, ili -NH2;
• -O-CH2-CO-RO4, gdje RO4 predstavlja hidroksi ili (C1-4)alkoksi; ili
• -O-CH2-O-CO-RO5, gdje RO5 predstavlja (C1-4)alkil ili (C1-4)alkoksi;
• -NRN1RN2, gdje RN1 neovisno predstavlja vodik ili (C1-3)alkil, i RN2 predstavlja –CO-H;
• 5-okso-4,5-dihidro-[1,2,4]oksadiazol-3-il, ili 3-okso-2,3-dihidro-[1,2,4]oksadiazol-5-il;
• 1H-tetrazol-5-il;
• 3-hidroksi-izoksazol-5-il;
• imidazolil koji je nesupstituiran, ili monosupstituiran ili disupstituiran s metilom;
• pirazolil;
• izoksazolil, oksazolil, ili tiadiazolil; gdje je spomenuti izoksazolil, oksazolil, ili tiadiazolil monosupstituiran s -NRN9RN10, dok RN9 predstavlja vodik, i RN10 predstavlja vodik ili metil;
i preostali jedan ili dva od navedenih supstituenata (ako postoje), neovisno se biraju od sljedećih:
• (C1-4)alkil;
• (C1-4)alkoksi;
• 2,2,2-trifluoroetoksi;
• halogen;
• -NRN1RN2, gdje RN1 predstavlja vodik, i RN2 predstavlja (C1-3)alkil;
• -S-RS2 gdje RS2 predstavlja (C1-4)alkil;
• ili Ar1 predstavlja 8-člani do 10-člani biciklički heteroaril odabran od nesupstituiranog benzimidazola; nesupstituiranog indazolila, i indolila koji je nesupstituiran ili monosupstituiran sa -COORO2 gdje RO2 predstavlja vodik ili (C1-4)alkil;
• ili Ar1 predstavlja okso-supstituiran 8-člani do 10-člani djelomično aromatski staljeni biciklički heterociklil koji se bira od sljedećih: 2-okso-2,3-dihidro-benzooksazolil, 3-okso-2,3-dihidro-1H-indazolil, 2-okso-1,2,3,4-tetrahidro-kinazolinil, 1-okso-1,2,3,4-tetrahidro-izokinolinil; gdje je spomenuti okso-supstituirani heterociklil nesupstituiran ili monosupstituiran na prstenovom atomu dušika sa (C1-3)alkilom;
ili njegova farmaceutski prihvatljiva sol.
11. Spoj prema patentnom zahtjevu 1, naznačen time, da se bira iz skupine koja se sastoji od sljedećih:
3-Kloro-5-{6-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
[6-(2,3-Dihidro-1H-indol-5-il)-pirimidin-4-il]-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etil]-amin;
[2-(7-Fluoro-2,4-dimetil-indol-1-il)-etil]-{6-[4-(1H-imidazol-4-il)-fenil]-pirimidin-4-il}-amin;
3-Etil-5-{6-[2-(6-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-metil-tiofen-2-karboksilna kiselina;
5-{6-[2-(4-Kloro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etil-5-{6-[2-(4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Kloro-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
4-{6-[2-(7-Fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-2-metilamino-benzojeva kiselina;
5-{6-[2-(5,7-Difluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
{6-[4-(3-Amino-izoksazol-5-il)-fenil]-pirimidin-4-il}-[2-(4-metoksi-2-metil-indol-1-il)-etil]-amin;
[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[4-(1H-imidazol-4-il)-fenil]-pirimidin-4-il}-amin;
[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[4-(1H-imidazol-4-il)-fenil]-pirimidin-4-il}-amin;
[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[4-(2H-pirazol-3-il)-fenil]-pirimidin-4-il}-amin;
3-Etoksi-5-{6-[2-(4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(6-Kloro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(7-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(7-fluoro-2,5-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(6-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etil-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(4,6-Dikloro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(4-Kloro-6-fluoro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(4-Kloro-7-fluoro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-6-fluoro-4-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
4-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-metilamino-benzojeva kiselina;
5-{6-[2-(7-Kloro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(4,6,7-trifluoro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(4,5,7-trifluoro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(6,7-Difluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
{6-[4-(3-Amino-izoksazol-5-il)-fenil]-pirimidin-4-il}-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etil]-amin;
[2-(6,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[4-(1H-imidazol-4-il)-fenil]-pirimidin-4-il}-amin;
[2-(7-Fluoro-2,4-dimetil-indol-1-il)-etil]-{6-[4-(5-metilamino-[1,3,4]tiadiazol-2-il)-fenil]-pirimidin-4-il}-amin;
5-{6-[2-(2-Cijano-6-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
2-Etilamino-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
5-{6-[2-(6,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(6-Fluoro-2,4-dimetil-indol-1-il)-etilamino]-2-metil-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
5-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
5-{6-[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[4-(5-metilamino-[1,3,4]tiadiazol-2-il)-fenil]-pirimidin-4-il}-amin;
4-(4-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-tiazol-2-karboksilna kiselina;
2-Kloro-4-{6-[2-(6-kloro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-6-propil-benzojeva kiselina;
2-Kloro-4-{6-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-6-propil-benzojeva kiselina;
5-{6-[2-(6,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
4-{6-[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-izobutil-benzojeva kiselina;
5-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-2-metil-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
5-{6-[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-2-metil-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
1-Etil-3-(4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-metoksi-fenil)-urea;
{6-[4-(2-Amino-oksazol-5-il)-fenil]-pirimidin-4-il}-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etil]-amin;
{6-[4-(2-Amino-oksazol-5-il)-fenil]-pirimidin-4-il}-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etil]-amin;
2-(4-{6-[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-tiazol-4-karboksilna kiselina;
2-(4-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-tiazol-4-karboksilna kiselina;
[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[4-(2-metil-1H-imidazol-4-il)-fenil]-pirimidin-4-il}-amin;
[2-(6-Fluoro-2,4-dimetil-indol-1-il)-etil]-{6-[4-(5-metilamino-[1,3,4]tiadiazol-2-il)-fenil]-pirimidin-4-il}-amin;
4-{6-[2-(2-Cijano-6-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-izobutil-benzojeva kiselina;
2-Kloro-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-6-propoksi-benzojeva kiselina;
2-Butoksi-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
{6-[4-(2-Amino-oksazol-5-il)-fenil]-pirimidin-4-il}-[2-(6,7-difluoro-4-metoksi-2-metil-indol-1-il)-etil]-amin;
[2-(6,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[4-(2-metil-1H-imidazol-4-il)-fenil]-pirimidin-4-il}-amin;
[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[4-(5-metilamino-[1,3,4]tiadiazol-2-il)-fenil]-pirimidin-4-il}-amin;
{6-[3-Etoksi-4-(1H-tetrazol-5-il)-fenil]-pirimidin-4-il}-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etil]-amin;
{6-[3-Etilamino-4-(1H-tetrazol-5-il)-fenil]-pirimidin-4-il}-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etil]-amin;
[2-(7-Kloro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[3-etilamino-4-(1H-tetrazol-5-il)-fenil]-pirimidin-4-il}-amin;
{6-[3-Etilamino-4-(1H-tetrazol-5-il)-fenil]-pirimidin-4-il}-[2-(4-metoksi-2-metil-indol-1-il)-etil]-amin;
{6-[3-Etilamino-4-(1H-tetrazol-5-il)-fenil]-pirimidin-4-il}-[2-(7-fluoro-2,4-dimetil-indol-1-il)-etil]-amin;
3-Butoksi-5-{6-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Butoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-propoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-izopropoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-izopropoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-propoksi-tiofen-2-karboksilna kiselina;
3-(4-{6-[2-(6,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-4H-[1,2,4]oksadiazol-5-on;
2-Kloro-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-6-izobutoksi-benzojeva kiselina;
[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-[6-(1H-indol-5-il)-pirimidin-4-il]-amin;
[2-(6,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etil]-[6-(1H-indol-5-il)-pirimidin-4-il]-amin;
6-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-1,2-dihidro-indazol-3-on;
4-{6-[2-(2-Kloro-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina;
5-{6-[2-(2-Kloro-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(4-Bromo-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[5-(1H-tetrazol-5-il)-tiofen-2-il]-pirimidin-4-il}-amin;
5-{6-[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-hidroksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-izopropoksi-tiofen-2-karboksilna kiselina;
1-(2-{6-[3-Etoksi-4-(1H-tetrazol-5-il)-fenil]-pirimidin-4-ilamino}-etil)-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-fluoro-tiofen-2-karboksilna kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina;
(4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenoksi)-octena kiselina;
N-(5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karbonil)-metansulfonamid;
(2-Etoksi-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
(2-Etoksi-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenilamino)-octena kiselina;
5-{6-[2-(2-Cijano-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
N-(5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karbonil)-benzensulfonamid;
Propan-2-sulfonska kiselina (5-{6-[2-(2-cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karbonil)-amid;
Ciklopropansulfonska kiselina (5-{6-[2-(2-cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karbonil)-amid;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina metilamid;
Etansulfonska kiselina (5-{6-[2-(2-cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karbonil)-amid;
7-Fluoro-1-(2-{6-[4-(1H-imidazol-4-il)-3-metoksi-fenil]-pirimidin-4-ilamino}-etil)-4-metoksi-1H-indol-2-karbonitril;
7-Fluoro-4-metoksi-1-(2-{6-[4-(5-metil-1H-imidazol-4-il)-fenil]-pirimidin-4-ilamino}-etil)-1H-indol-2-karbonitril;
1-(2-{6-[3-Etoksi-4-((5-okso-4,5-dihidro-[1,2,4]oksadiazol-3-il)-fenil]-pirimidin-4-ilamino}-etil)-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
1-(2-{6-[4-(2,5-Dimetil-1H-imidazol-4-il)-fenil]-pirimidin-4-ilamino}-etil)-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
1-{2-[6-(3-Etil-4-hidroksi-fenil)-pirimidin-4-ilamino]-etil}-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
1-(2-{6-[4-(1,5-Dimetil-1H-imidazol-4-il)-fenil]-pirimidin-4-ilamino}-etil)-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
1-(2-{6-[4-(1,2-Dimetil-1H-imidazol-4-il)-fenil]-pirimidin-4-ilamino}-etil)-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
7-Fluoro-1-(2-{6-[4-((5-okso-4,5-dihidro-[1,2,4]oksadiazol-3-il)-fenil]-pirimidin-4-ilamino}-etil)-4-metoksi-1H-indol-2-karbonitril;
7-Fluoro-1-(2-{6-[5-(3-hidroksi-oksetan-3-il)-4-metoksi-tiofen-2-il]-pirimidin-4-ilamino}-etil)-4-metoksi-1H-indol-2-karbonitril;
1-(2-{6-[4-(2-Ciklopropil-1-metil-1H-imidazol-4-il)-fenil]-pirimidin-4-ilamino}-etil)-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
(4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-trifluorometoksi-fenoksi)-octena kiselina;
7-Fluoro-1-(2-{6-[4-(3H-imidazol-4-il)-fenil]-pirimidin-4-ilamino}-etil)-4-metoksi-1H-indol-2-karbonitril;
3-(2-Etoksi-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-[1,2,4]oksadiazol-5(4H)-on;
7-Fluoro-1-(2-{6-[4-(3-okso-2,3-dihidro-1,2,4-oksadiazol-5-il)-fenil]-pirimidin-4-ilamino}-etil)-4-metoksi-1H-indol-2-karbonitril;
5-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-(2,2,2-trifluoro-etoksi)-tiofen-2-karboksilna kiselina;
(4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etil-fenoksi)-octena kiselina;
3-(2-Etoksi-4-{6-[2-(6-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-[1,2,4]oksadiazol-5(4H)-on;
2-Butoksi-6-kloro-4-(6-((2-(7-fluoro-4-metoksi-2-metil-1H-indol-1-il)etil-1,1,2,2-d4)amino)pirimidin-4-il)benzojeva kiselina;
5-{6-[2-(7-Kloro-5-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-(2,2,2-trifluoro-etoksi)-tiofen-2-karboksilna kiselina;
2-(2-Etoksi-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenilamino)-propionska kiselina;
5-{6-[2-(2-Cijano-3-fluoro-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-7-fluoro-4-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-fluoro-tiofen-2-karboksilna kiselina;
7-Fluoro-1-(2-{6-[4-(3-hidroksi-izoksazol-5-il)-fenil]-pirimidin-4-ilamino}-etil)-4-metoksi-1H-indol-2-karbonitril;
N-(4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenil)-oksalaminska kiselina;
7-Fluoro-1-(2-{6-[4-(3-hidroksi-izoksazol-5-il)-3-metoksi-fenil]-pirimidin-4-ilamino}-etil)-4-metoksi-1H-indol-2-karbonitril;
5-{6-[2-(2-Cijano-7-fluoro-4-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
(4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenilamino)-octena kiselina;
1-(2-{6-[4-(2-Ciklopropil-1H-imidazol-4-il)-fenil]-pirimidin-4-ilamino}-etil)-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
5-{6-[2-(6-Kloro-7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
(4-{6-[2-(2-Cijano-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenilamino)-octena kiselina;
7-Fluoro-1-{2-[6-(4-hidroksi-3-trifluorometoksi-fenil)-pirimidin-4-ilamino]-etil}-4-metoksi-1H-indol-2-karbonitril;
1-{2-[6-(3-Kloro-4-hidroksi-fenil)-pirimidin-4-ilamino]-etil}-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
5-{6-[2-(4,6-Dikloro-7-fluoro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(6-Kloro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-izopropoksi-tiofen-2-karboksilna kiselina;
(4-{6-[2-(2-Cijano-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenoksi)-octena kiselina;
5-{6-[2-(6-Kloro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
2-Butoksi-4-{6-[2-(2-cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-trifluorometoksi-fenol;
3-Etoksi-5-{6-[2-(3-fluoro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-3-fluoro-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
(2-Etoksi-4-{6-[2-(7-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-fenilamino)-octena kiselina;
2-Butoksi-4-{6-[2-(6,7-difluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
5-{6-[2-(2,4-Dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-3-izopropoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(2,4-Dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
3-(2-Etoksi-4-{6-[2-(4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-[1,2,4]oksadiazol-5(4H)-on;
5-{6-[2-(4,6-Dikloro-2-cijano-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-5,6-difluoro-4-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-7-fluoro-4-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-7-fluoro-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
(4-{6-[2-(2-Cijano-7-fluoro-4-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenoksi)-octena kiselina;
(4-{6-[2-(2-Cijano-7-fluoro-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenilamino)-octena kiselina;
1-{2-[6-(3-Etoksi-4-hidroksi-fenil)-pirimidin-4-ilamino]-etil}-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina amid;
5-{6-[2-(2-Cijano-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-fluoro-tiofen-2-karboksilna kiselina;
5-{6-[2-(4-Kloro-2-cijano-6,7-difluoro-indol-1-il)-etilamino]-pirimidin-4-il}-3-fluoro-tiofen-2-karboksilna kiselina;
2-Butoksi-4-{6-[2-(2-cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-6-fluoro-benzojeva kiselina;
2-Butoksi-6-kloro-4-{6-[2-(2-cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Kloro-4-{6-[2-(2-cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-6-propoksi-benzojeva kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-fluoro-6-propoksi-benzojeva kiselina;
5-{6-[2-(4-Kloro-2-cijano-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
5-{6-[2-(4-Kloro-2-cijano-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
5-{6-[2-(4-Kloro-2-cijano-6,7-difluoro-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
2-Kloro-4-{6-[2-(2-cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-6-izobutoksi-benzojeva kiselina;
(4-{6-[2-(4-Kloro-2-cijano-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenilamino)-octena kiselina;
(4-{6-[2-(4-Kloro-2-cijano-6,7-difluoro-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenilamino)-octena kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-difluorometoksi-benzojeva kiselina;
7-Fluoro-4-metoksi-1-{2-[6-(1-metil-2-okso-1,2,3,4-tetrahidro-quinazolin-7-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
7-Fluoro-4-metoksi-1-{2-[6-(1-metil-3-okso-2,3-dihidro-1H-indazol-6-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
3-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-5-etilsulfanil-benzojeva kiselina;
7-Fluoro-4-metoksi-1-(2-{6-[4-(3H-[1,2,3]triazol-4-il)-fenil]-pirimidin-4-ilamino}-etil)-1H-indol-2-karbonitril;
3-(3-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-5-etoksi-fenoksi)-propionska kiselina;
3-(4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenoksi)-propionska kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-3-fluoro-benzojeva kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzensulfonamid;
1-(2-{6-[3-Etoksi-4-(3H-[1,2,3]triazol-4-il)-fenil]-pirimidin-4-ilamino}-etil)-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
3-(5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-il)-propionska kiselina;
7-Fluoro-1-(2-{6-[4-(2-hidroksi-3,4-diokso-ciklobut-1-enil)-fenil]-pirimidin-4-ilamino}-etil)-4-metoksi-1H-indol-2-karbonitril;
(4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenil)-okso-octena kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-propilsulfanil-benzojeva kiselina;
4-{6-[2-(2-Cijano-6-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-propilsulfanil-benzojeva kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-izopropilsulfanil-benzojeva kiselina;
4-{6-[2-(2-Cijano-6-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-izopropilsulfanil-benzojeva kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-fluoro-6-propil-benzojeva kiselina;
5-{6-[2-(2-Cijano-5,7-difluoro-4-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-6,7-difluoro-4-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-6,7-difluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
(4-{6-[2-(2-Cijano-6,7-difluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenoksi)-octena kiselina;
(4-{6-[2-(2-Cijano-6,7-difluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenilamino)-octena kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-propil-benzojeva kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etil-benzojeva kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-izobutoksi-benzojeva kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-propoksi-benzojeva kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-etilsulfanil-benzojeva kiselina;
4-{6-[2-(2-Cijano-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etilsulfanil-benzojeva kiselina;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etilsulfanil-benzojeva kiselina;
4-{6-[2-(2-Cijano-6-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etilsulfanil-benzojeva kiselina;
4-{6-[2-(2-Cijano-6,7-difluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etilsulfanil-benzojeva kiselina;
4-{6-[2-(2-Cijano-6,7-difluoro-4-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina;
4-{6-[2-(2-Cijano-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-metilamino-benzojeva kiselina;
2-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-1H-indol-5-karboksilna kiselina;
7-Fluoro-1-{2-[6-(1H-indol-2-il)-pirimidin-4-ilamino]-etil}-4-metoksi-1H-indol-2-karbonitril;
2-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-1H-indol-5-karboksilna kiselina metil ester;
7-Fluoro-1-(2-{6-[4-(2-hidroksi-etoksi)-fenil]-pirimidin-4-ilamino}-etil)-4-metoksi-1H-indol-2-karbonitril;
7-Fluoro-1-{2-[6-(1H-indol-6-il)-pirimidin-4-ilamino]-etil}-4-metoksi-1H-indol-2-karbonitril;
7-Fluoro-4-metoksi-1-{2-[6-(1H-pirrolo[2,3-c]piridin-3-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
7-Fluoro-1-{2-[6-(1H-indol-3-il)-pirimidin-4-ilamino]-etil}-4-metoksi-1H-indol-2-karbonitril;
7-Fluoro-4-metoksi-1-{2-[6-(2-okso-1,2,3,4-tetrahidro-quinazolin-6-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
N-(4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-formamid;
7-Fluoro-4-metoksi-1-{2-[6-(2-okso-2,3-dihidro-benzooksazol-6-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
7-Fluoro-4-metoksi-1-{2-[6-(3-metil-2-okso-2,3-dihidro-benzooksazol-5-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
7-Fluoro-1-{2-[6-(1H-indazol-5-il)-pirimidin-4-ilamino]-etil}-4-metoksi-1H-indol-2-karbonitril;
7-Fluoro-4-metoksi-1-{2-[6-(1H-pirrolo[2,3-b]piridin-3-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
7-Fluoro-4-metoksi-1-{2-[6-(1H-pirrolo[2,3-b]piridin-5-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
7-Fluoro-4-metoksi-1-{2-[6-(1-metil-1H-pirrolo[2,3-b]piridin-5-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
1-(4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-metoksi-fenil)-3-etil-urea;
1-{2-[6-(1H-Benzoimidazol-5-il)-pirimidin-4-ilamino]-etil}-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
1-{2-[6-(3H-Benzotriazol-5-il)-pirimidin-4-ilamino]-etil}-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
7-Fluoro-4-metoksi-1-{2-[6-(1-okso-1,2,3,4-tetrahidro-izokinolin-6-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
1-{2-[6-(3-Etoksi-4-, tvoreil-fenil)-pirimidin-4-ilamino]-etil}-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
7-Fluoro-1-{2-[6-(1H-indol-5-il)-pirimidin-4-ilamino]-etil}-4-metoksi-1H-indol-2-karbonitril;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-fluoro-benzojeva kiselina metil ester;
7-Fluoro-1-{2-[6-(4-hidroksi-3-trifluorometil-fenil)-pirimidin-4-ilamino]-etil}-4-metoksi-1H-indol-2-karbonitril;
3-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-5-etoksi-benzojeva kiselina;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-3-karboksilna kiselina etil ester;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-metilamino-benzojeva kiselina;
4-{6-[2-(5,7-Difluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-2-metilamino-benzojeva kiselina;
3-(5-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-izopropoksi-tiofen-2-il)-propionska kiselina;
3-(3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-propionska kiselina;
(E)-3-(3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-akrilna kiselina;
4-{6-[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-metilamino-benzojeva kiselina;
3-Kloro-5-{6-[2-(4-kloro-2-cijano-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Kloro-5-{6-[2-(4-kloro-2-cijano-6,7-difluoro-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
N-(3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karbonil)-metansulfonamid;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina etilamid;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina dimetilamid;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina (2-hidroksi-etil)-amid;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina izopropilamid;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina (2-metoksi-etil)-amid;
5-(6-((2-(2-Cijano-7-fluoro-4-metoksi-1H-indol-1-il)etil)amino)pirimidin-4-il)-3-etoksi-N-sulfamoiltiofen-2-karboksamid;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina hidroksiamid;
(3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-metanol;
2-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-4-izopropoksi-tiazol-5-karboksilna kiselina;
2-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-4-metoksi-tiazol-5-karboksilna kiselina;
4-Etoksi-2-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiazol-5-karboksilna kiselina;
2-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-4-propoksi-tiazol-5-karboksilna kiselina;
2-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-4-izobutil-tiazol-5-karboksilna kiselina;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina karboksimetil ester;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina dimetilkarbamoilmetil ester;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina butiriloksimetil ester;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina etoksikarboniloksimetil ester;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina 5-metil-2-okso-[1,3]dioksol-4-ilmetil ester;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina 2-dimetilamino-etil ester;
5-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina fenil ester;
(4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-metoksi-fenil)-propionska kiselina etil ester;
{6-[4-Etoksi-5-(1H-tetrazol-5-il)-tiofen-2-il]-pirimidin-4-il}-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etil]-amin;
3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-N-hidroksi-tiofen-2-karboksamidin;
3-(3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-[1,2,4]oksadiazol-5(4H)-on;
5-{6-[2-(3,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[5-(2H-tetrazol-5-il)-4-trifluorometil-tiofen-2-il]-pirimidin-4-il}-amin;
5-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-N-hidroksi-3-trifluorometil-tiofen-2-karboksamidin;
3-(5-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-il)-[1,2,4]oksadiazol-5(4H)-on;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-N-hidroksi-benzamid;
5-(3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-izoksazol-3-ol;
5-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-piridin-2-il-tiofen-2-karboksilna kiselina;
[6-(4-Etilamino-tiofen-2-il)-pirimidin-4-il]-[2-(7-fluoro-2,4-dimetil-indol-1-il)-etil]-amin;
[6-(4-Etilamino-tiofen-2-il)-pirimidin-4-il]-[2-(6-fluoro-2,4-dimetil-indol-1-il)-etil]-amin;
[6-(4-Etilamino-tiofen-2-il)-pirimidin-4-il]-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etil]-amin;
N-Etil-N-(5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-3-il)-formamid;
N-(3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-formamid;
N-(3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-propionamid;
N-(3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-3-hidroksi-propionamid;
(3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-urea; i
5-{6-[2-(2-Cijano-3,7-difluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
ili njihova farmaceutski prihvatljiva sol.
12. Spoj prema patentnom zahtjevu 1, naznačen time, da se bira iz skupine koja se sastoji od sljedećih:
3-Kloro-5-{6-[2-(4-kloro-7-fluoro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Kloro-5-{6-[2-(6-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
(2-Kloro-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-metanol;
5-{6-[2-(7-Fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-3-metil-tiofen-2-karboksilna kiselina;
[6-(2,3-Dihidro-1H-indol-5-il)-pirimidin-4-il]-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etil]-amin;
[2-(6-Fluoro-2,4-dimetil-indol-1-il)-etil]-{6-[4-(1H-imidazol-4-il)-fenil]-pirimidin-4-il}-amin;
[2-(4-Metoksi-2-metil-indol-1-il)-etil]-{6-[4-(2H-pirazol-3-il)-fenil]-pirimidin-4-il}-amin;
{6-[4-(1H-Imidazol-4-il)-fenil]-pirimidin-4-il}-[2-(4-metoksi-2-metil-indol-1-il)-etil]-amin;
[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-[6-(2-metil-1H-benzoimidazol-5-il)-pirimidin-4-il]-amin;
3-Etil-5-{6-[2-(7-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Fluoro-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Fluoro-5-{6-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
(4-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-metoksi-fenil)-metanol;
(2-Etoksi-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-metanol;
[2-(6,7-Difluoro-2,4-dimetil-indol-1-il)-etil]-{6-[4-(1H-imidazol-4-il)-fenil]-pirimidin-4-il}-amin;
5-{6-[2-(4,5-Difluoro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
5-{6-[2-(5-Kloro-7-fluoro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
2-Etilamino-4-{6-[2-(6-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Etilamino-4-{6-[2-(7-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Etilamino-4-{6-[2-(4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
3-Etoksi-5-{6-[2-(4-metoksi-2,7-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
3-Etoksi-5-{6-[2-(5,6,7-trifluoro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
[2-(6,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etil]-[6-(4-[1,2,4]oksadiazol-5-il-fenil)-pirimidin-4-il]-amin;
[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[4-(1-metil-1H-pirazol-3-il)-fenil]-pirimidin-4-il}-amin;
3-(4-{6-[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-4H-[1,2,4]oksadiazol-5-on;
4-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-propil-benzojeva kiselina;
1-Etil-3-(2-metoksi-4-{6-[2-(4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-urea;
2-Kloro-6-etilamino-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-(6-kinolin-6-il-pirimidin-4-il)-amin;
2-Etilamino-6-fluoro-4-{6-[2-(7-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(7-Kloro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-etilamino-benzojeva kiselina;
2-Kloro-4-{6-[2-(6-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-6-propil-benzojeva kiselina;
2-Kloro-4-{6-[2-(7-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-6-propil-benzojeva kiselina;
2-Fluoro-4-{6-[2-(7-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-6-propil-benzojeva kiselina;
4-{6-[2-(5,7-Difluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina;
2-Kloro-4-{6-[2-(4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-6-propil-benzojeva kiselina;
{6-[4-(2-Amino-5-metil-tiazol-4-il)-fenil]-pirimidin-4-il}-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etil]-amin;
5-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-propil-2,3-dihidro-izoindol-1-on;
2-Ciklobutoksi-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(2-Cijano-6-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina;
2-Etilamino-6-fluoro-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(6,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina;
4-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-propoksi-benzojeva kiselina;
4-{6-[2-(5,7-Difluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-2-izobutil-benzojeva kiselina;
2-Kloro-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-6-propil-benzojeva kiselina;
2-Fluoro-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-6-propil-benzojeva kiselina;
2-Fluoro-4-{6-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-6-propil-benzojeva kiselina;
2-Butoksi-4-{6-[2-(7-fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(7-Fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-2-izobutoksi-benzojeva kiselina;
4-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-izobutil-benzojeva kiselina;
2-(4-{6-[2-(7-Fluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-tiazol-4-karboksilna kiselina;
[2-(6-Fluoro-2,4-dimetil-indol-1-il)-etil]-{6-[4-(2-metil-1H-imidazol-4-il)-fenil]-pirimidin-4-il}-amin;
2-(4-{6-[2-(4-Metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-tiazol-4-karboksilna kiselina;
4-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-trifluorometil-benzensulfonamid;
{6-[4-(5-Amino-[1,3,4]tiadiazol-2-il)-fenil]-pirimidin-4-il}-[2-(6-fluoro-2,4-dimetil-indol-1-il)-etil]-amin;
[2-(6,7-Difluoro-2,4-dimetil-indol-1-il)-etil]-{6-[4-(2-metil-1H-imidazol-4-il)-fenil]-pirimidin-4-il}-amin;
4-(4-{6-[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-tiazol-2-karboksilna kiselina;
[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-{6-[4-(5-metil-1H-pirazol-3-il)-fenil]-pirimidin-4-il}-amin;
4-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-(2,2,2-trifluoro-etilamino)-benzojeva kiselina;
2-Ciklopentiloksi-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
2-Butoksi-4-{6-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
4-{6-[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-izobutoksi-benzojeva kiselina;
4-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-izobutoksi-benzojeva kiselina;
4-{6-[2-(6,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-izobutil-benzojeva kiselina;
4-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-2-metil-pirimidin-4-il}-2-izobutil-benzojeva kiselina;
2-Kloro-4-{6-[2-(5,7-difluoro-2,4-dimetil-indol-1-il)-etilamino]-pirimidin-4-il}-6-propoksi-benzojeva kiselina;
4-{6-[2-(6,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-fluoro-6-propoksi-benzojeva kiselina;
4-{6-[2-(6,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-(2,2,2-trifluoro-etilamino)-benzojeva kiselina;
[2-(5-Kloro-7-metil-[1,3]dioksolo[4,5-e]indol-6-il)-etil]-{6-[3-etilamino-4-(1H-tetrazol-5-il)-fenil]-pirimidin-4-il}-amin;
{6-[3-Etoksi-4-(1H-tetrazol-5-il)-fenil]-pirimidin-4-il}-[2-(7-fluoro-2,4-dimetil-indol-1-il)-etil]-amin;
{6-[3-Etoksi-4-(1H-tetrazol-5-il)-fenil]-pirimidin-4-il}-[2-(4-metoksi-2-metil-indol-1-il)-etil]-amin;
3-(4-{6-[2-(6-Kloro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenil)-4H-[1,2,4]oksadiazol-5-on;
2-Kloro-4-{6-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-6-izobutoksi-benzojeva kiselina;
[2-(6-Fluoro-2,4-dimetil-indol-1-il)-etil]-[6-(1H-indol-5-il)-pirimidin-4-il]-amin;
[2-(7-Fluoro-2,4-dimetil-indol-1-il)-etil]-[6-(1H-indol-5-il)-pirimidin-4-il]-amin;
[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-[6-(1H-indol-5-il)-pirimidin-4-il]-amin;
[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-[6-(1-metil-1H-indol-5-il)-pirimidin-4-il]-amin;
[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-[6-(1-metil-1H-indol-5-il)-pirimidin-4-il]-amin;
[2-(6,7-Difluoro-4-metoksi-2-metil-indol-1-il)-etil]-[6-(1-metil-1H-indol-5-il)-pirimidin-4-il]-amin;
2-Kloro-4-{6-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-6-(2,2,2-trifluoro-etoksi)-benzojeva kiselina;
2-Kloro-4-{6-[2-(6,7-difluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-6-(2,2,2-trifluoro-etoksi)-benzojeva kiselina;
2-Kloro-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-6-(2,2,2-trifluoro-etoksi)-benzojeva kiselina;
[2-(6-Fluoro-4-metoksi-2-metil-indol-1-il)-etil]-[6-(4-pirazin-2-il-fenil)-pirimidin-4-il]-amin;
6-{6-[2-(7-Kloro-5-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-1,2-dihidro-indazol-3-on;
3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-1-metil-etilamino]-pirimidin-4-il}-tiofen-2-karboksilna kiselina;
5-{6-[2-(7-Fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-hidroksi-tiofen-2-karboksilna kiselina;
1-(3-Etoksi-5-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-tiofen-2-il)-etanol;
(2-Etoksi-4-{6-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenilamino)-octena kiselina metil ester;
7-Fluoro-4-metoksi-1-{2-[6-(2-trifluorometil-piridin-4-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
3-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-5-metoksi-benzojeva kiselina;
7-Fluoro-4-metoksi-1-{2-[6-(2-okso-2,3-dihidro-1H-benzoimidazol-5-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-N-(2-metoksi-etil)-benzamid;
7-Fluoro-1-[2-(6-imidazo[1,2-a]piridin-6-il-pirimidin-4-ilamino)-etil]-4-metoksi-1H-indol-2-karbonitril;
7-Fluoro-1-{2-[6-(2-okso-2,3-dihidro-1H-benzo[d]imidazol-5-il)-pirimidin-4-ilamino]-etil}-4-metoksi-1H-indol-2-karbonitril;
1-{2-[6-(2-Ciklopropil-piridin-4-il)-pirimidin-4-ilamino]-etil}-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
1-{2-[6-(2-Azetidin-1-il-piridin-4-il)-pirimidin-4-ilamino]-etil}-7-fluoro-4-metoksi-1H-indol-2-karbonitril;
4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
7-Fluoro-4-metoksi-1-{2-[6-(2-metil-3-okso-2,3-dihidro-1H-indazol-6-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
7-Fluoro-4-metoksi-1-{2-[6-(3-metoksi-1H-indazol-6-il)-pirimidin-4-ilamino]-etil}-1H-indol-2-karbonitril;
(4-{6-[2-(4-Kloro-2-cijano-6,7-difluoro-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenoksi)-octena kiselina;
5-{6-[2-(4-Kloro-2-cijano-indol-1-il)-etilamino]-pirimidin-4-il}-3-fluoro-tiofen-2-karboksilna kiselina;
5-{6-[2-(2-Cijano-7-fluoro-indol-1-il)-etilamino]-pirimidin-4-il}-3-fluoro-tiofen-2-karboksilna kiselina;
(4-{6-[2-(2-Cijano-5,6-difluoro-4-metil-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-fenilamino)-octena kiselina;
5-{6-[2-(7-Kloro-5-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
2-Butoksi-4-{6-[2-(6-kloro-7-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-benzojeva kiselina;
5-{6-[2-(4,7-Dikloro-5-fluoro-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-3-etoksi-tiofen-2-karboksilna kiselina;
(2-Etoksi-4-{6-[2-(6-fluoro-4-metoksi-2-metil-indol-1-il)-etilamino]-pirimidin-4-il}-fenilamino)-octena kiselina;
5-{6-[2-(2-Cijano-7-fluoro-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
5-{6-[2-(4,6-Dikloro-2-cijano-indol-1-il)-etilamino]-pirimidin-4-il}-3-trifluorometil-tiofen-2-karboksilna kiselina;
5-{6-[2-(4,6-Dikloro-2-cijano-indol-1-il)-etilamino]-pirimidin-4-il}-3-fluoro-tiofen-2-karboksilna kiselina;
[6-(3-Etoksi-4-oksazol-2-il-fenil)-pirimidin-4-il]-[2-(7-fluoro-4-metoksi-2-metil-indol-1-il)-etil]-amin; i
(2-Kloro-4-{6-[2-(2-cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-fenoksi)-octena kiselina;
ili njihova farmaceutski prihvatljiva sol.
13. Spoj prema patentnom zahtjevu 1, naznačen time, da on jest 4-{6-[2-(2-Kloro-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina, ili njezina farmaceutski prihvatljiva sol.
14. Spoj prema patentnom zahtjevu 1, naznačen time, da on jest 4-{6-[2-(2-Cijano-7-fluoro-4-metoksi-indol-1-il)-etilamino]-pirimidin-4-il}-2-etoksi-benzojeva kiselina, ili njezina farmaceutski prihvatljiva sol.
15. Farmaceutski pripravak, naznačen time, da kao aktivni sastojak, on sadrži spoj prema bilo kojem od patentnih zahtjeva 1 do 14, ili njegovu farmaceutski prihvatljivu sol, i najmanje jedno terapijski inertno pomoćno sredstvo.
16. Spoj prema bilo kojem od patentnih zahtjeva 1 do 14, ili njegova farmaceutski prihvatljiva sol, naznačen time, da se upotrebljava kao lijek.
17. Spoj prema bilo kojem od patentnih zahtjeva 1 do 14, ili njegova farmaceutski prihvatljiva sol, naznačen time, da je za uporabu u prevenciji ili liječenju bolesti koje se biraju iz skupine koju čine rak; bol; endometrioza; autosomalna dominantna policistična bolest bubrega; akutni ishemijski sindromi kod ateroskleroznih pacijenata; pneumonija; i neurodegenerativne bolesti; ili je za uporabu u kontroliranju ženske plodnosti.
18. Spoj prema bilo kojem od patentnih zahtjeva 1 do 14, ili njegova farmaceutski prihvatljiva sol, naznačen time, da je za uporabu u prevenciji ili liječenju raka koji se bira od melanoma; raka pluća; raka mokraćnog mjehura; bubrežnih karcinoma; gastrointestinalnih vrsta raka; endometrijskog raka; raka jajnika; raka grlića maternice; i neuroblastoma.
19. Uporaba spoja prema bilo kojem od patentnih zahtjeva 1 do 14, ili njegove farmaceutski prihvatljive soli, naznačena time, da je za proizvodnju lijeka za prevenciju ili liječenje bolesti koje se biraju iz skupine koju čine rak; bol; endometrioza; autosomalna dominantna policistična bolest bubrega; akutni ishemijski sindromi kod ateroskleroznih pacijenata; pneumonija; i neurodegenerativne bolesti; ili je za kontroliranje ženske plodnosti.
20. Spoj prema bilo kojem od patentnih zahtjeva 1 do 14, ili njegova farmaceutski prihvatljiva sol, naznačen time, da je za uporabu u postupku modulacije imunosnog odgovora kod pojedinca koji ima tumor; pri čemu navedeni postupak reaktivira imunosni sustav u tumoru spomenutog pojedinca.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP2015077269 | 2015-11-20 | ||
EP16797577.0A EP3377483B9 (en) | 2015-11-20 | 2016-11-17 | N-substituted indole derivatives as pge2 receptor modulators |
PCT/EP2016/078028 WO2017085198A1 (en) | 2015-11-20 | 2016-11-17 | N-substituted indole derivatives as pge2 receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20211678T1 true HRP20211678T1 (hr) | 2022-03-04 |
Family
ID=57326428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20211678TT HRP20211678T1 (hr) | 2015-11-20 | 2016-11-17 | N-supstituirani derivati indola kao modulatori receptora pge2 |
Country Status (33)
Country | Link |
---|---|
US (2) | US11241431B2 (hr) |
EP (2) | EP3377483B9 (hr) |
JP (2) | JP2018534328A (hr) |
KR (1) | KR102352022B1 (hr) |
CN (1) | CN108349949B (hr) |
AU (1) | AU2016358242B2 (hr) |
BR (1) | BR112018010291B1 (hr) |
CA (1) | CA3002610C (hr) |
CL (1) | CL2018001325A1 (hr) |
CO (1) | CO2018005715A2 (hr) |
CR (1) | CR20180323A (hr) |
CY (1) | CY1124913T1 (hr) |
DK (1) | DK3377483T3 (hr) |
EA (1) | EA037953B1 (hr) |
ES (1) | ES2897954T3 (hr) |
HR (1) | HRP20211678T1 (hr) |
HU (1) | HUE056679T2 (hr) |
IL (1) | IL259424B (hr) |
LT (1) | LT3377483T (hr) |
MA (2) | MA55046A (hr) |
MX (1) | MX2018005268A (hr) |
MY (1) | MY195888A (hr) |
PE (1) | PE20181304A1 (hr) |
PH (1) | PH12018501077B1 (hr) |
PL (1) | PL3377483T3 (hr) |
PT (1) | PT3377483T (hr) |
RS (1) | RS62598B1 (hr) |
SA (1) | SA518391588B1 (hr) |
SG (1) | SG11201803627XA (hr) |
SI (1) | SI3377483T1 (hr) |
TW (2) | TWI754397B (hr) |
UA (1) | UA123441C2 (hr) |
WO (1) | WO2017085198A1 (hr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CR20180323A (es) * | 2015-11-20 | 2018-08-06 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituídos como moduladores de los receptores de pge2 |
HUE056382T2 (hu) | 2017-05-18 | 2022-02-28 | Idorsia Pharmaceuticals Ltd | Pirimidin-származékok mint PGE2 receptor modulátorok |
TW201900179A (zh) | 2017-05-18 | 2019-01-01 | 瑞士商愛杜西亞製藥有限公司 | 作為pge2受體調節劑之苯并呋喃及苯并噻吩衍生物 |
CA3063788A1 (en) | 2017-05-18 | 2018-11-22 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives |
DK3625222T3 (da) | 2017-05-18 | 2021-10-25 | Idorsia Pharmaceuticals Ltd | Phenylderivater som pge2-receptormodulatorer |
CN109678780A (zh) * | 2017-10-19 | 2019-04-26 | 中国石油化工股份有限公司 | 一种制备3-烷基吲哚衍生物的方法 |
WO2019100062A1 (en) | 2017-11-20 | 2019-05-23 | Ichan School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
EP3735419A4 (en) | 2018-01-05 | 2021-09-15 | Icahn School of Medicine at Mount Sinai | PROCESS FOR INCREASING THE PROLIFERATION OF PANCREATIC BETA CELLS, PROCESS OF TREATMENT AND COMPOSITION |
EP3768267A4 (en) | 2018-03-20 | 2022-04-20 | Icahn School of Medicine at Mount Sinai | KINA INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE |
WO2020142486A1 (en) * | 2018-12-31 | 2020-07-09 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
EP3693359A1 (en) * | 2019-02-08 | 2020-08-12 | Medibiofarma, S.L. | New n-benzyl-2-phenoxybenzamide derivatives as prostaglandin e2 (pge2) receptors modulators |
WO2021060281A1 (ja) * | 2019-09-24 | 2021-04-01 | Agc株式会社 | プロスタグランジンe2レセプターep2/ep4デュアルアンタゴニスト |
TW202228674A (zh) | 2020-11-13 | 2022-08-01 | 日商小野藥品工業股份有限公司 | 藉由併用ep4拮抗藥與免疫檢查點抑制物質而進行之癌症治療 |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5948786A (en) | 1996-04-12 | 1999-09-07 | Sumitomo Pharmaceuticals Company, Limited | Piperidinylpyrimidine derivatives |
AU2000234451B2 (en) | 2000-03-24 | 2005-09-29 | Asterand Uk Acquisition Limited | Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists |
HN2001000224A (es) | 2000-10-19 | 2002-06-13 | Pfizer | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos. |
GB0031302D0 (en) | 2000-12-21 | 2001-01-31 | Glaxo Group Ltd | Napthalene derivatives |
GB0031295D0 (en) | 2000-12-21 | 2001-01-31 | Glaxo Group Ltd | Naphthalene derivatives |
GB0103269D0 (en) | 2001-02-09 | 2001-03-28 | Glaxo Group Ltd | Napthalene derivatives |
MXPA04009961A (es) | 2002-04-12 | 2004-12-13 | Pfizer | Compuestos de imidazol como agentes anti-inflamatorios y analgesicos. |
MXPA04009960A (es) | 2002-04-12 | 2004-12-13 | Pfizer | Compuestos de pirazol como agentes anti-inflamatorios y analgesicos. |
CN1662551A (zh) | 2002-05-23 | 2005-08-31 | 瑟瑞技术公司 | 前列腺素e2受体亚型ep4的拮抗肽 |
CN100408570C (zh) | 2003-01-29 | 2008-08-06 | 阿斯特兰德英国有限公司 | Ep4受体拮抗剂 |
CA2536887C (en) | 2003-08-26 | 2012-03-06 | Teijin Pharma Limited | Pyrrolopyrimidinone derivatives |
EP1663979B1 (en) | 2003-09-03 | 2013-10-09 | RaQualia Pharma Inc. | Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists |
US8084457B2 (en) | 2003-09-15 | 2011-12-27 | Lead Discovery Center Gmbh | Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |
GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
WO2005080367A1 (en) | 2004-02-12 | 2005-09-01 | Pharmagene Laboratories Limited | Ep2 receptor agonists |
CN1950333A (zh) | 2004-05-04 | 2007-04-18 | 辉瑞大药厂 | 取代的甲基芳基或杂芳基酰胺化合物 |
WO2005105733A1 (en) | 2004-05-04 | 2005-11-10 | Pfizer Japan Inc. | Ortho substituted aryl or heteroaryl amide compounds |
GT200500284A (es) * | 2004-10-15 | 2006-03-27 | Aventis Pharma Inc | Pirimidinas como antagonistas del receptor de prostaglandina d2 |
ATE533766T1 (de) | 2005-05-19 | 2011-12-15 | Merck Canada Inc | Chinolinderivate als ep4-antagonisten |
WO2006128129A2 (en) | 2005-05-26 | 2006-11-30 | Synta Pharmaceuticals Corp. | Method for treating cancer |
AR060403A1 (es) | 2006-04-12 | 2008-06-11 | Sanofi Aventis | Compuestos de amino- pirimidina 2,6- sustituidos -4- monosustituidos como antagonistas del receptor de prostaglandina d2 |
WO2007121578A1 (en) | 2006-04-24 | 2007-11-01 | Merck Frosst Canada Ltd. | Indole amide derivatives as ep4 receptor antagonists |
WO2007143825A1 (en) | 2006-06-12 | 2007-12-21 | Merck Frosst Canada Ltd. | Indoline amide derivatives as ep4 receptor ligands |
US20080280891A1 (en) | 2006-06-27 | 2008-11-13 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
WO2008008059A1 (en) | 2006-07-12 | 2008-01-17 | Locus Pharmaceuticals, Inc. | Anti-cancer agents ans uses thereof |
EP2044056B1 (en) * | 2006-07-14 | 2012-08-22 | Novartis AG | Pyrimidine derivatives as alk-5 inhibitors |
CA2660133C (en) | 2006-08-11 | 2015-10-27 | Merck Frosst Canada Ltd. | Thiophenecarboxamide derivatives as ep4 receptor ligands |
WO2008039882A1 (en) | 2006-09-30 | 2008-04-03 | Sanofi-Aventis U.S. Llc | A combination of niacin and a prostaglandin d2 receptor antagonist |
AU2008221194B2 (en) | 2007-02-26 | 2013-06-27 | Merck Canada Inc. | Indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists |
US8030489B2 (en) | 2007-03-26 | 2011-10-04 | Astellas Pharma Inc. | Ornithine derivative |
CN101636385B (zh) | 2007-03-26 | 2012-09-05 | 默克弗罗斯特加拿大有限公司 | 作为ep4受体拮抗剂的萘和喹啉磺酰脲衍生物 |
EP2014657A1 (de) * | 2007-06-21 | 2009-01-14 | Bayer Schering Pharma Aktiengesellschaft | Diaminopyrimidine als Modulatoren des EP2-Rezeptors |
EP2172447A4 (en) | 2007-07-03 | 2011-08-24 | Astellas Pharma Inc | amide |
DK2212297T3 (da) | 2007-10-12 | 2011-09-05 | Ingenium Pharmaceuticals Gmbh | Inhibitorer af proteinkinaser |
WO2009105220A1 (en) | 2008-02-19 | 2009-08-27 | Janssen Pharmaceutica N.V. | Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase |
EP2565191B1 (en) | 2008-05-14 | 2014-10-08 | Astellas Pharma Inc. | 4-(Indol-7-ylcarbonylaminomethyl)cyclohexanecarboxylic acid derivatives as EP4 receptor antagonists useful for the treatment of chronic renal failure or diabetic nephropathy |
US20130225528A1 (en) | 2008-05-21 | 2013-08-29 | Ariad Pharmaceuticals, Inc. | Phosphorus Derivatives as Kinase Inhibitors |
EP2320906B1 (en) | 2008-08-14 | 2016-02-24 | Beta Pharma Canada Inc. | Heterocyclic amide derivatives as ep4 receptor antagonists |
CN102164942B (zh) | 2008-09-19 | 2017-02-15 | 生物科技研究有限公司 | 三萜系化合物及其使用的方法 |
CA2737618A1 (en) | 2008-09-25 | 2010-04-01 | Merck Frosst Canada Ltd. | Beta-carboline sulphonylurea derivatives as ep4 receptor antagonists |
WO2011022348A1 (en) | 2009-08-18 | 2011-02-24 | Janssen Pharmaceutica Nv | Ethylene diamine modulators of fatty acid amide hydrolase |
CN102711757A (zh) | 2009-11-23 | 2012-10-03 | 莱西肯医药有限公司 | 用于治疗肠易激综合征的方法和分析法 |
JP5607241B2 (ja) | 2010-05-21 | 2014-10-15 | ケミリア・エービー | 新規ピリミジン誘導体 |
CN103097358B (zh) | 2010-09-21 | 2015-04-08 | 卫材R&D管理有限公司 | 药物组合物 |
DK2623594T5 (en) | 2010-09-29 | 2015-09-21 | Nb Health Lab Co Ltd | Antibody against human prostaglandin E2 receptor EP4 |
JP2013542967A (ja) | 2010-11-17 | 2013-11-28 | ノバルティス アーゲー | 3−(アミノアリール)−ピリジン化合物 |
WO2012066065A1 (en) | 2010-11-17 | 2012-05-24 | Novartis Ag | Phenyl-heteroaryl amine compounds and their uses |
CA2820109C (en) | 2010-12-10 | 2018-01-09 | Rottapharm S.P.A. | Pyridine amide derivatives as ep4 receptor antagonists |
WO2012103071A2 (en) | 2011-01-25 | 2012-08-02 | Eisai R&D Management Co., Ltd. | Compounds and compositions |
US9006241B2 (en) * | 2011-03-24 | 2015-04-14 | Noviga Research Ab | Pyrimidine derivatives |
EP2702043A1 (en) | 2011-04-29 | 2014-03-05 | Exelixis, Inc. | Inhibitors of inducible form of 6-phosphofructose-2-kinase |
US9518044B2 (en) | 2011-06-20 | 2016-12-13 | Emory University | Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto |
RU2565596C2 (ru) | 2011-07-04 | 2015-10-20 | Роттафарм Биотек С.Р.Л. | Производные циклических аминов в качестве антагонистов рецептора ер4 |
EP2554662A1 (en) | 2011-08-05 | 2013-02-06 | M Maria Pia Cosma | Methods of treatment of retinal degeneration diseases |
US20150004175A1 (en) | 2011-12-13 | 2015-01-01 | Yale University | Compositions and Methods for Reducing CTL Exhaustion |
CN106977495B (zh) | 2012-04-24 | 2020-08-04 | 沃泰克斯药物股份有限公司 | Dna-pk抑制剂 |
AR091429A1 (es) | 2012-06-29 | 2015-02-04 | Lilly Co Eli | Compuestos de fenoxietil piperidina |
TWI572597B (zh) | 2012-06-29 | 2017-03-01 | 美國禮來大藥廠 | 二甲基-苯甲酸化合物 |
EP2711364A1 (en) * | 2012-09-21 | 2014-03-26 | Chemilia AB | 4-(Indolyl or benzimidazolyl)amino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer |
CN105143206B (zh) | 2012-11-27 | 2019-01-15 | 托马斯·黑勒戴药物研究基金会 | 用于治疗癌症的嘧啶-2,4-二胺衍生物 |
UA115576C2 (uk) | 2012-12-06 | 2017-11-27 | Байєр Фарма Акцієнгезелльшафт | Похідні бензимідазолу як антагоністи ер4 |
EP2765128A1 (en) | 2013-02-07 | 2014-08-13 | Almirall, S.A. | Substituted benzamides with activity towards EP4 receptors |
TW201443004A (zh) | 2013-02-15 | 2014-11-16 | Lilly Co Eli | 苯氧基乙氧基化合物 |
TWI636046B (zh) | 2013-05-17 | 2018-09-21 | 美國禮來大藥廠 | 苯氧基乙基二氫-1h-異喹啉化合物 |
MX369804B (es) | 2013-06-12 | 2019-11-21 | Kaken Pharma Co Ltd | Derivado de 4-alquinil imidazol y medicamento que los comprende como ingrediente activo. |
WO2015034820A1 (en) | 2013-09-04 | 2015-03-12 | Bristol-Myers Squibb Company | Compounds useful as immunomodulators |
MX365218B (es) | 2013-09-06 | 2019-05-27 | Aurigene Discovery Tech Ltd | Derivados de 1,2,4-oxadiazol como inmunomoduladores. |
WO2015044900A1 (en) | 2013-09-27 | 2015-04-02 | Aurigene Discovery Technologies Limited | Therapeutic immunomodulating compounds |
EP3424920B1 (en) | 2013-10-17 | 2020-04-15 | Vertex Pharmaceuticals Incorporated | Co-crystals of (s)-n-methyl-8-(1-((2'-methyl-[4,5'-bipyrimidin]-6-yl)amino)propan-2-yl)quinoline-4-carboxamide and deuterated derivatives thereof as dna-pk inhibitors |
TR201807411T4 (tr) | 2013-10-17 | 2018-06-21 | Vertex Pharma | DNA-PK inhibitörleri. |
PL3083554T3 (pl) | 2013-12-17 | 2019-08-30 | Eli Lilly & Company | Związki kwasu dimetylobenzoesowego |
KR101807981B1 (ko) | 2013-12-17 | 2017-12-11 | 일라이 릴리 앤드 캄파니 | 페녹시에틸 시클릭 아민 유도체 및 ep4 수용체 조절제로서의 그의 활성 |
TW201607943A (zh) | 2013-12-19 | 2016-03-01 | 拜耳製藥公司 | 作為ep4配體之新穎苯并咪唑衍生物 |
TW201623277A (zh) | 2014-03-26 | 2016-07-01 | 安斯泰來製藥股份有限公司 | 醯胺化合物 |
US10052332B2 (en) | 2014-04-29 | 2018-08-21 | Emory University | Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto |
KR102535283B1 (ko) | 2014-05-23 | 2023-05-22 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 암의 치료를 위한 조합 요법 |
JP6635949B2 (ja) | 2014-06-04 | 2020-01-29 | トーマス・ヘレデイズ・スティフテルス・フォー・メディシンスク・フォルスクニング | 炎症性および自己免疫性の病気の処置のためのmth1阻害剤 |
WO2016021742A1 (en) | 2014-08-07 | 2016-02-11 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds as ep4 receptor antagonists |
ES2839203T3 (es) | 2015-01-09 | 2021-07-05 | Ono Pharmaceutical Co | Compuesto espiro tricíclico |
EP3325490B1 (en) | 2015-07-23 | 2019-12-18 | Takeda Pharmaceutical Company Limited | 1-substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as ep4 receptor antagonists |
US10316040B2 (en) | 2015-10-16 | 2019-06-11 | Eisai R&D Management Co., Ltd. | EP4 antagonists |
CR20180323A (es) * | 2015-11-20 | 2018-08-06 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituídos como moduladores de los receptores de pge2 |
WO2018013840A1 (en) | 2016-07-13 | 2018-01-18 | Vertex Pharmaceuticals Incorporated | Methods, compositions and kits for increasing genome editing efficiency |
CA3063788A1 (en) | 2017-05-18 | 2018-11-22 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives |
DK3625222T3 (da) | 2017-05-18 | 2021-10-25 | Idorsia Pharmaceuticals Ltd | Phenylderivater som pge2-receptormodulatorer |
MX2019013639A (es) | 2017-05-18 | 2020-01-21 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituidos. |
HUE056382T2 (hu) | 2017-05-18 | 2022-02-28 | Idorsia Pharmaceuticals Ltd | Pirimidin-származékok mint PGE2 receptor modulátorok |
TW201900179A (zh) | 2017-05-18 | 2019-01-01 | 瑞士商愛杜西亞製藥有限公司 | 作為pge2受體調節劑之苯并呋喃及苯并噻吩衍生物 |
-
2015
- 2015-11-20 CR CR20180323A patent/CR20180323A/es unknown
-
2016
- 2016-11-17 MA MA055046A patent/MA55046A/fr unknown
- 2016-11-17 JP JP2018526184A patent/JP2018534328A/ja not_active Ceased
- 2016-11-17 HR HRP20211678TT patent/HRP20211678T1/hr unknown
- 2016-11-17 PL PL16797577T patent/PL3377483T3/pl unknown
- 2016-11-17 EA EA201891179A patent/EA037953B1/ru unknown
- 2016-11-17 KR KR1020187017474A patent/KR102352022B1/ko active IP Right Grant
- 2016-11-17 LT LTEPPCT/EP2016/078028T patent/LT3377483T/lt unknown
- 2016-11-17 CA CA3002610A patent/CA3002610C/en active Active
- 2016-11-17 US US15/777,597 patent/US11241431B2/en active Active
- 2016-11-17 RS RS20211424A patent/RS62598B1/sr unknown
- 2016-11-17 EP EP16797577.0A patent/EP3377483B9/en active Active
- 2016-11-17 PE PE2018000994A patent/PE20181304A1/es unknown
- 2016-11-17 MY MYPI2018701873A patent/MY195888A/en unknown
- 2016-11-17 SI SI201631400T patent/SI3377483T1/sl unknown
- 2016-11-17 EP EP21186831.0A patent/EP3928836A1/en active Pending
- 2016-11-17 UA UAA201806812A patent/UA123441C2/uk unknown
- 2016-11-17 PT PT167975770T patent/PT3377483T/pt unknown
- 2016-11-17 AU AU2016358242A patent/AU2016358242B2/en active Active
- 2016-11-17 SG SG11201803627XA patent/SG11201803627XA/en unknown
- 2016-11-17 HU HUE16797577A patent/HUE056679T2/hu unknown
- 2016-11-17 MX MX2018005268A patent/MX2018005268A/es active IP Right Grant
- 2016-11-17 DK DK16797577.0T patent/DK3377483T3/da active
- 2016-11-17 WO PCT/EP2016/078028 patent/WO2017085198A1/en active Application Filing
- 2016-11-17 CN CN201680066933.8A patent/CN108349949B/zh active Active
- 2016-11-17 MA MA43251A patent/MA43251B1/fr unknown
- 2016-11-17 BR BR112018010291-1A patent/BR112018010291B1/pt active IP Right Grant
- 2016-11-17 ES ES16797577T patent/ES2897954T3/es active Active
- 2016-11-18 TW TW109133855A patent/TWI754397B/zh active
- 2016-11-18 TW TW105137938A patent/TWI719078B/zh active
-
2018
- 2018-05-15 SA SA518391588A patent/SA518391588B1/ar unknown
- 2018-05-16 IL IL259424A patent/IL259424B/en active IP Right Grant
- 2018-05-17 CL CL2018001325A patent/CL2018001325A1/es unknown
- 2018-05-18 PH PH12018501077A patent/PH12018501077B1/en unknown
- 2018-05-30 CO CONC2018/0005715A patent/CO2018005715A2/es unknown
-
2021
- 2021-04-13 JP JP2021067831A patent/JP7228618B2/ja active Active
- 2021-11-30 CY CY20211101035T patent/CY1124913T1/el unknown
- 2021-12-13 US US17/549,828 patent/US20220175775A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20211678T1 (hr) | N-supstituirani derivati indola kao modulatori receptora pge2 | |
JP2018534328A5 (hr) | ||
JP5036316B2 (ja) | アリールオキシ置換ベンズイミダゾール誘導体 | |
US9592235B2 (en) | Aminoquinazoline and pyridopyrimidine derivatives | |
HRP20201469T1 (hr) | Derivati tetrahidroizokinolina | |
CA2671744A1 (en) | Compounds and compositions as protein kinase inhibitors | |
US20220388964A1 (en) | (aza)indazolyl-aryl sulfonamide and related compounds and their use in treating medical conditions | |
JP2017501205A (ja) | 治療用阻害化合物 | |
TW201202221A (en) | Nitrogen containing heteroaryl compounds | |
US11524959B1 (en) | Indole and azaindole inhibitors of pad enzymes | |
MX2014000867A (es) | Quinolinas sustituidas y su uso como medicamentos. | |
JPWO2005063737A1 (ja) | アミドピラゾール誘導体 | |
CN111868037B (zh) | 作为crhr2拮抗剂的稠合环状脲衍生物 | |
JP2016518344A5 (hr) | ||
RU2015144386A (ru) | Циклоалкилнитрилпиразолопиридоны в качестве ингибиторов янус-киназы | |
US6987122B2 (en) | 2-(1H-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity | |
AU2024200054A1 (en) | Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof | |
JPWO2016204261A1 (ja) | アミノピラゾール誘導体 | |
JP2023546352A (ja) | Bcr-ablチロシンキナーゼの阻害のための5-及び6-アザインドール化合物 | |
JP2023539553A (ja) | タンパク質分泌阻害剤 | |
CN103443107B (zh) | 噻唑并嘧啶化合物 | |
JP7264833B2 (ja) | ヘテロシクリルメチリデン誘導体およびmGluR5受容体のモジュレーターとしてのそれらの使用 | |
JPWO2020203609A5 (hr) |